Two piece electrode assembly with gap for plasma control

Information

  • Patent Grant
  • 10699879
  • Patent Number
    10,699,879
  • Date Filed
    Tuesday, April 17, 2018
    6 years ago
  • Date Issued
    Tuesday, June 30, 2020
    4 years ago
Abstract
An apparatus for distributing plasma products includes first and second electrodes that each include planar surfaces. The first electrode forms first apertures from a first planar surface to a second planar surface; the second electrode forms second apertures from the third planar surface to the fourth planar surface. The electrodes couple through one or more adjustable couplers such that the third planar surface is disposed adjacent to the second planar surface with a gap therebetween, the gap having a gap distance. Each of the adjustable couplers has a range of adjustment. The first and second apertures are arranged such that for at least one position within the ranges of adjustment, none of the first apertures aligns with any of the second apertures to form an open straight-line path extending through both the first and second electrodes, and the gap distance is between 0.005 inch and 0.050 inch.
Description
TECHNICAL FIELD

The present disclosure relates to plasma processing systems.


BACKGROUND

In plasma processing, plasmas create species such as radicals, excited molecular species, molecular fragments, individual atoms and/or free electrons from a source gas. Mixtures of such species, with or without untransformed portions of the source gas, and with or without further gases mixed in, are called “plasma products” herein. Plasma processing brings plasma products into contact with workpieces that may be, for example, semiconductor wafers. To create and/or maintain a plasma, one or more radio frequency (RF) and/or microwave generators typically provide electromagnetic power to a region that contains the source gas. The plasma can be generated from the source gas in the location of one or more wafers being processed, and/or in a first, “upstream” location, after which the plasma products move to a second, “downstream” location to contact the wafer(s). Some systems generate one, two or more plasmas in different locations before the plasma products ultimately contact the wafer(s). Source gases, plasma products and/or other gases mixed with the plasma products often contain highly energetic, charged and/or corrosive species, and/or highly energetic electrons, such that the plasma equipment can sometimes degrade from contact with these materials. This can make materials and/or coatings of plasma system components critical to the longevity and maintenance requirements of the system. Wafer processing can also be affected, and therefore controlled by, the relative presence or absence of certain components of plasma products.


SUMMARY

In one or more embodiments, an apparatus for distributing plasma products includes a first electrode and a second electrode. The first electrode includes a first planar surface and a second planar surface separated by a first electrode thickness that is between 0.125 inch and 1.000 inch. The first electrode forms a plurality of first apertures extending therethrough, from the first planar surface to the second planar surface. The second electrode includes a third planar surface and a fourth planar surface separated by a second electrode thickness that is between 0.125 inch and 1.000 inch. The second electrode forms a plurality of second apertures extending therethrough, from the third planar surface to the fourth planar surface. The second electrode couples with the first electrode through one or more adjustable couplers such that the third planar surface is disposed adjacent to the second planar surface with a gap therebetween, the gap being characterized by a gap distance. Each of the one or more adjustable couplers has a range of adjustment. For at least a first position within the range of adjustment of each of the one or more adjustable couplers, the first and second apertures are arranged within the first and second electrodes, such that none of the first apertures aligns with any of the second apertures to form an open straight-line path extending through both the first and second electrodes, and the gap distance is between 0.005 inch and 0.050 inch.


In one or more embodiments, an apparatus for distributing plasma products includes a first electrode and a second electrode. The first electrode includes a first planar surface and a second planar surface separated by a first electrode thickness that is between 0.125 inch and 1.000 inch. The first electrode forms a plurality of first apertures extending therethrough, from the first planar surface to the second planar surface. The second electrode includes a third planar surface and a fourth planar surface separated by a second electrode thickness that is between 0.125 inch and 1.000 inch. The second electrode is coupled fixedly with the first electrode such that the third planar surface is disposed adjacent to the second planar surface, with a gap distance of 0.005 inches to 0.050 inches therebetween. The first and second apertures are arranged within the first and second electrodes such that none of the first apertures aligns with any of the second apertures to form an open straight-line path extending through both the first and second electrodes.


In one or more embodiments, a plasma source includes a plasma generation region configured for introduction of one or more source gases therein, an RF power supply that provides electromagnetic power to the one or more source gases to ignite a plasma within the plasma generation region, and a two piece electrode assembly that bounds the plasma generation region on one side. The two piece electrode assembly includes a first electrode that defines a first planar surface and a second planar surface. The first planar surface and the second planar surface are separated by a first electrode thickness that is between 0.100 inch and 1.000 inch, and the first electrode forms a plurality of first apertures extending therethrough, from the first planar surface to the second planar surface. The two piece electrode assembly also includes a second electrode that defines a third planar surface and a fourth planar surface. The third planar surface and the fourth planar surface separated by a second electrode thickness that is between 0.100 inch and 1.000 inch, and the second electrode forms a plurality of second apertures extending therethrough, from the third planar surface to the fourth planar surface. The first electrode and the second electrode are fixed or positionable with respect to one another so as to provide a gap between the first electrode and the second electrode, the gap forming a gap distance of 0.005 inches to 0.050 inches between the second planar surface and the third planar surface, and a lateral separation of any point within one of the first apertures, with respect to any point within any of the second apertures, of greater than three times the gap distance. The plasma source further includes a second region that is bounded on at least one side by the fourth planar surface of the second electrode, wherein the gap and the lateral separation cooperate to substantially reduce transmission of free electrons and ionized species from the plasma generation region to the second region.


In one or more embodiments, a method for providing plasma products includes converting at least a portion of a source gas to plasma products, by providing electromagnetic power to the source gas within a plasma generation chamber to generate a plasma, and passing at least a portion of the plasma products through a two piece electrode assembly. The two piece electrode assembly includes a first electrode and a second electrode. The first electrode defines a plurality of first apertures therethrough, a first side of the first electrode facing the plasma such that the portion of the plasma products passes through the plurality of first apertures to a second planar side of the first planar electrode. The second electrode defines a plurality of second apertures therethrough, a third planar side of the second electrode being disposed facing the second side of the first electrode. The second electrode is coupled with the first electrode such that the third planar surface is disposed adjacent to the second planar surface, with a gap distance therebetween. The first and second apertures are arranged within the first and second electrodes such that none of the first apertures aligns with any of the second apertures to form an open straight-line path extending through both the first and second electrodes. The gap distance is sufficient to allow neutral species of the plasma products to pass through the gap as the first portion of the plasma products, but is sufficiently small to cause ionized species of the plasma products to interact with the first or second electrodes and not to pass through the two piece electrode assembly.


In one or more embodiments, a method for optimizing a plasma apparatus includes providing a plasma generation chamber, a downstream chamber, and a two piece electrode assembly therebetween that is operable to modify fluid communication between the plasma generation chamber and the downstream chamber. The two piece electrode assembly includes a first electrode, a second electrode and one or more actuators. The first electrode defines a plurality of first apertures therethrough, a first surface of the first electrode facing the plasma generation chamber and a second planar surface of the first electrode facing away from the plasma generation chamber. The second electrode that defines a plurality of second apertures therethrough, a third planar surface of the second electrode being disposed facing the second planar surface of the first electrode, and a fourth surface of the second electrode facing the downstream chamber. The one or more actuators couple the first and second electrodes, and are operable, in response to an electronic input, to adjust a position of the first electrode relative to a position of the second electrode. The one or more actuators can be operated to provide at least one position of the first electrode relative to the second electrode such that the third planar surface is disposed adjacent to the second planar surface, with a first gap distance between 0.005 inch and 0.050 inch therebetween, and the first and second apertures are arranged within the first and second electrodes such that none of the first apertures aligns with any of the second apertures to form an open straight-line path extending through both the first and second electrodes. The method further includes: establishing a position of the first electrode at a first position relative to the position of the second electrode; operating the plasma generation chamber so as to flow at least a portion of plasma products generated thereby, through the two piece electrode assembly and into the downstream chamber, to process a workpiece; evaluating process results on the workpiece; and operating the electronic input so as to modify the position of the first electrode to a second position relative to the position of the second electrode, in response to the process results.


In one or more embodiments, a method for optimizing a plasma apparatus includes providing a plasma generation chamber, a downstream chamber, and a two piece electrode assembly therebetween that is operable to modify fluid communication between the plasma generation chamber and the downstream chamber. The two piece electrode assembly includes a first electrode, a second electrode and an actuator. The first electrode defines a plurality of first apertures therethrough, a first surface of the first electrode facing the plasma generation chamber and a second planar surface of the first electrode facing away from the plasma generation chamber. The second electrode that defines a plurality of second apertures therethrough, a third planar surface of the second electrode being disposed facing the second planar surface of the first electrode, and a fourth surface of the second electrode facing the downstream chamber. The actuator couples with the first and second electrodes, and is operable to adjust a gap distance between the second and third planar surfaces, the actuator being characterized by a known distance response to an electronic input. The method further includes: operating the electronic input so as to bring a portion of the first electrode into contact with a portion of the second electrode; establishing the electronic input that brings the portion of the first electrode into contact with the portion of the second electrode as a zero value of the electronic input; and further operating the electronic input, relative to the zero value, so as to maintain the gap distance at a desired value, according to the known distance response, to modify the fluid communication between the plasma generation chamber and the downstream chamber.


In one or more embodiments, a method of operating a plasma apparatus includes providing a plasma generation chamber, a downstream chamber, and a two piece electrode assembly therebetween that is operable to modify fluid communication between the plasma generation chamber and the downstream chamber. The two piece electrode assembly includes a first electrode, a second electrode and one or more actuators coupled with the first and second electrodes. The one or more actuators are operable to adjust a position of the first electrode relative to the second electrode. Each of the one or more actuators is characterized by a range of adjustment. For at least one position within the ranges of adjustment of the one or more actuators, the first and second apertures are arranged within the first and second electrodes such that none of the first apertures aligns with any of the second apertures to form an open straight-line path extending through both the first and second electrodes, and the gap distance is between 0.0005 inch and 0.050 inch. The method further includes: operating the one or more actuators so as to dispose the first electrode at a first position relative to the second electrode; operating the plasma generation chamber so as to flow at least a first portion of plasma products generated thereby, through the two piece electrode assembly and into the downstream chamber; operating the one or more actuators so as to dispose the first electrode at a second position relative to the second electrode; and operating the plasma generation chamber so as to flow at least a second portion of plasma products generated thereby, through the two piece electrode assembly and into the downstream chamber. A difference between the first position and the second position causes the two piece electrode assembly to modify a proportion of ionized species to neutral species in the second portion relative to the first portion.





BRIEF DESCRIPTION OF THE DRAWINGS

The present disclosure may be understood by reference to the following detailed description taken in conjunction with the drawings briefly described below, wherein like reference numerals are used throughout the several drawings to refer to similar components. For purposes of illustrative clarity, certain elements in the drawings may not be drawn to scale. Specific instances of an item may be referred to by use of a numeral followed by a second numeral within parentheses (e.g., electrodes 326(1), 326(2) etc.) while numerals not followed by a dash refer to any such item (e.g., electrodes 326). In instances where multiple instances of an item are shown, only some of the instances may be labeled, for clarity of illustration.



FIG. 1 schematically illustrates major elements of a plasma processing system, in a plan view, according to one or more embodiments.



FIG. 2 schematically illustrates a portion of a plasma processing system, in a cross-sectional view, according to one or more embodiments.



FIG. 3 schematically illustrates a portion of a faceplate that forms multiple apertures, according to one or more embodiments.



FIG. 4 schematically illustrates a portion of a two part electrode assembly, in a cross-sectional view, according to one or more embodiments.



FIG. 5 schematically illustrates a portion of another two part electrode assembly, in a cross-sectional view, according to one or more embodiments.



FIG. 6A schematically illustrates a two part electrode assembly that includes two electrodes and an adjustable coupler, in a cross-sectional view, according to one or more embodiments.



FIG. 6B schematically illustrates a portion noted within FIG. 6A, in an enlarged view, according to one or more embodiments.



FIG. 7 schematically illustrates a two piece electrode assembly with two actuators for adjusting vertical position of one electrode with respect to another electrode, in a cross-sectional view, according to one or more embodiments.



FIG. 8 schematically illustrates an assembly with six actuators for adjusting position of a ring with respect to an underlying support portion, in a plan view, according to one or more embodiments.



FIG. 9A schematically illustrates a layout of apertures that could be formed in an electrode of a two piece electrode assembly, in a plan view, according to one or more embodiments.



FIG. 9B schematically illustrates a layout that includes the apertures illustrated in FIG. 9A, and apertures of a second electrode, also in a rectangular arrangement, in a plan view, according to one or more embodiments.



FIG. 9C schematically illustrates a layout that includes the apertures illustrated in FIGS. 9A and 9B, with one of the sets of apertures shifted, in a plan view, according to one or more embodiments.



FIG. 10A schematically illustrates a layout of apertures in hexagonal arrangements that can be formed in each of an upper and a lower electrode, in a plan view, according to one or more embodiments.



FIG. 10B schematically illustrates the a layout of apertures shown in FIG. 10A, with one of the sets of apertures shifted such that a small overlap occurs between each pair of apertures, in a plan view, according to one or more embodiments.



FIG. 11 schematically illustrates a layout of apertures in a radial arrangement, in a plan view, according to one or more embodiments.



FIG. 12 schematically illustrates a layout in which one set of apertures has been rotated relative to another set of apertures, in a plan view, according to one or more embodiments.



FIG. 13 schematically illustrates another layout in which one set of apertures has been rotated relative to another set of apertures, in a plan view, according to one or more embodiments.



FIG. 14 is a schematic diagram illustrating major components of a plasma processing system, according to one or more embodiments.



FIG. 15 is a flowchart of a method for providing plasma products, according to one or more embodiments.



FIG. 16 is a flowchart of a method for providing plasma products, according to one or more embodiments.



FIG. 17 is a flowchart of a method for providing plasma products, according to one or more embodiments.



FIG. 18 is a flowchart of a method for providing plasma products, according to one or more embodiments.





In the appended figures, similar components and/or features may have the same reference label. Further, various components of the same type may be distinguished by following the reference label by a numeral that distinguishes among the similar components. If only the first reference label is used in the specification, the description is applicable to any one of the similar components having the same first reference label irrespective of the numeral. Also, several of the figures are included as schematics. It is to be understood that the figures are for illustrative purposes, and are not to be considered of scale unless specifically stated to be of scale. Additionally, as schematics, the figures are provided to aid comprehension and may not include all aspects or information compared to realistic representations, and may include superfluous or exaggerated material for illustrative purposes.


Additional embodiments and features are set forth in part in the description that follows, and in part will become apparent to those skilled in the art upon examination of the specification or may be learned by the practice of the invention. The features and advantages of the invention may be realized and attained by means of the instrumentalities, combinations, and methods described in the specification.


DETAILED DESCRIPTION


FIG. 1 schematically illustrates, in a top plan view, major elements of a plasma processing system 100, that may include deposition, etching, baking, and/or curing chambers according to embodiments. System 100 is depicted as a single wafer, semiconductor wafer plasma processing system, but it will be apparent to one skilled in the art that the techniques and principles herein are applicable to plasma generation systems of any type (e.g., systems that do not necessarily process wafers or semiconductors).


In FIG. 1, a pair of front opening unified pods (FOUPs) 102 supply substrates that can be received by robotic arms 104 and placed into a low pressure holding area 106, before being placed into one of processing chambers 108a-f, positioned in tandem sections 109a-c. A second robotic arm 110 may be used to transport the substrates from the holding area 106 to the processing chambers 108a-f and back. Each processing chamber 108a-f can be outfitted to perform one or more processing operations. including dry etch processes, cyclical layer deposition (CLD), atomic layer deposition (ALD), chemical vapor deposition (CVD), physical vapor deposition (PVD), etches, pre-cleans, bakes, cures, degassing, orientation, and other processes.


Processing chambers 108a-f may include one or more system components for depositing, annealing, curing and/or etching materials on the substrates. In one configuration, two pairs of the processing chambers, e.g., 108c-d and 108e-f, may be used to deposit material(s) on the substrates, and the third pair of processing chambers, e.g., 108a-b, may be used to etch the deposited material(s) and/or the substrates. In another configuration, all three pairs of chambers, e.g., 108a-f, may be configured to etch deposited material(s) and/or the substrates. Any one or more of the processes described may be carried out in chamber(s) separated from the fabrication system shown in different embodiments. It will be appreciated that additional configurations of deposition, etching, annealing, and curing chambers for dielectric films are contemplated by system 100. Certain manufacturers may prefer systems with the flexibility of igniting and/or using plasmas in a variety of configurations, so that each system can be adapted for a corresponding variety of processing needs. The techniques disclosed herein may be adapted to plasma processing systems that ignite and/or use plasmas formed at single or multiple locations.


Although some portions of the present disclosure identify etch processes utilizing the disclosed apparatus and methods, it is to be understood that the apparatus and methods are equally applicable to deposition and cleaning processes as may occur in the described chambers. Accordingly, the technology should not be considered to be so limited as for use with etching processes or chambers alone. Moreover, although an exemplary chamber is described to provide foundation for the present technology, it is to be understood that the present technology can be applied to virtually any semiconductor processing chamber that may allow the single-chamber operations described. Furthermore, it is noted that the term “chamber” as used herein should be understood as either a cavity in which a wafer or other workpiece is processed through contact with plasma products, or the structure and apparatus that forming such cavity and/or provide such plasma products.



FIG. 2 shows a cross-sectional view that schematically illustrates a portion of an exemplary plasma processing system 200. Plasma processing system 200 is an example of plasma processing unit 100, FIG. 1. During etching, a process gas may be flowed into a first plasma generation chamber 215 through a gas inlet assembly 205. A remote plasma system (RPS) 201 may optionally be included in the system, and may process a first gas which then travels through gas inlet assembly 205. Inlet assembly 205 may include two or more distinct gas supply channels where the second channel (not shown) may bypass RPS 201, if included. In the orientation of FIG. 2, a general direction of gas and/or plasma product flow is downwards, and this direction may be referred to as “downstream” herein, while an opposing direction upwards in the orientation of FIG. 2, may be referred to as “upstream.” This convention of directions may be used herein, although one skilled in the art will understand that many of the principles described herein are not limited to systems oriented as shown in FIG. 2.


A cooling plate 203, a faceplate 217, an ion suppressor 223, a showerhead 225, and a workpiece support or pedestal 265, with a workpiece 255 disposed thereon, are shown and may each be included according to embodiments. Pedestal 265 may form one or more heat exchange channels through which a heat exchange fluid flows to control the temperature of the substrate, so as to heat and/or cool the workpiece during processing operations. A wafer support platter of pedestal 265 may be formed of aluminum, aluminum alloys, ceramics, or combinations thereof, may also be resistively heated in order to achieve relatively high temperatures, such as from about 100° C. to about 1100° C. or above, using an embedded resistive heater element.


Each of faceplate 217, ion suppressor 223, and showerhead 225 forms apertures for source gases and/or plasma products to pass through for uniform delivery of source gases and/or plasma products to a downstream workpiece processing region 233; such apertures should be understood as present, but not shown in FIG. 2 for clarity of illustration. Also, although FIG. 2 illustrates each of faceplate 217, ion suppressor 223, and showerhead 225 as solid for clarity of illustration, these components may be formed of multiple parts, as discussed below. Faceplate 217 may be pyramidal, conical, or of another similar structure with a narrow top portion expanding to a wide bottom portion. Faceplate 217 may additionally be flat, as shown.


A portion of system 200 that lies directly above workpiece 255 and extending upwards through at least showerhead 225, ion suppressor 223, and faceplate 217, is called herein a working area 251 of system 200. When workpiece 255 is round (e.g., a semiconductor wafer) working area 251 will also be round. The usual goal of components such as faceplate 217, ion suppressor 223, and showerhead 225 is to distribute gases and plasma products as uniformly as possible within the working area. However, certain embodiments herein can provide one or more added degrees of process control that can, for example, skew or correct processing across working area 251, or introduce radial or other spatial patterns of process effects within working area 251, as discussed below.


Exemplary configurations may include having gas inlet assembly 205 open into a gas supply region 258, that is partitioned from first plasma generation chamber 215 by faceplate 217 so that source gases (or plasma products, if RPS 201 is used) flow through the apertures in faceplate 217 into first plasma generation chamber 215. Structural and operational features may be selected to prevent significant backflow of plasma from first plasma generation chamber 215 back into supply region 258, gas inlet assembly 205, and fluid supply system 210. Faceplate 217, or a conductive top portion of the chamber, and showerhead 225 are shown with an insulating ring 220 located therebetween, to allow a power supply an alternating current (AC) potential to be applied to the faceplate 217 relative to showerhead 225 and/or ion suppressor 223. A power supply that provides the AC potential is called an RF power supply herein, although the power supplied might be in the radio frequency (RF) spectrum or the microwave spectrum. The AC potential enables formation of a capacitively coupled plasma (CCP) in first plasma generation chamber 215. Additional features such as baffles (not shown) may additionally be located in the first plasma generation chamber 215, or otherwise coupled with gas inlet assembly 205, to affect the flow of source gases and/or plasma products through gas inlet assembly 205 into first plasma generation chamber 215.


It should be noted that components such as cooling plate 203, faceplate 217, ion suppressor 223, showerhead 225 and/or other diffusers or screens herein may be characterized as electrodes, as any such components may be individually tied to electrical potentials. Surfaces of any of these components that are exposed to plasma and/or plasma products may be coated either with ceramic layers (e.g., yttria, alumina) or with a suitable passivating layer (e.g., an anodized layer, or a chemically generated alumina layer) for chemical resistance.


Processing system 200 may further include a power supply 240 electrically coupled with any or all of faceplate 217, ion suppressor 223, showerhead 225, and/or pedestal 265 to generate a plasma in first plasma generation chamber 215 and/or processing region 233. Power supply 240 may be configured to deliver an adjustable amount of power to the appropriate electrode(s) depending on the process performed. Such a configuration may allow for a tunable plasma to be used in the processes being performed. Unlike a remote plasma unit, which typically includes on or off functionality, a tunable plasma may be configured to deliver a specific amount of power to first plasma generation chamber 215 and/or processing region 233. This in turn may allow development of particular plasma characteristics such that source gases may be transformed to specific plasma products to enhance processing objectives such as etching profiles, selectivity, uniformity and the like.


In use, a plasma 216 may be ignited either in first plasma generation chamber 215, and/or a plasma 230 may be ignited in workpiece processing region 233, for example to produce plasma products from a fluorine-containing source gas or other source gas for etching. For example, while source gases are supplied, an AC voltage, typically in the radio frequency (RF) range, may be generated by power supply 240 and applied between the conductive top portion of the processing chamber, such as faceplate 217, and showerhead 225 and/or ion suppressor 223 to ignite plasma 216 in first plasma generation chamber 215. Similarly, with source gases (and/or plasma products from first plasma generation chamber 215) flowing, an AC voltage may be applied between showerhead 225 and pedestal 265 to ignite plasma 230 in processing region 233. Power supply 240 may operate at an RF frequency of 13.56 MHz but may also operate at other frequencies, alone or in combination with the 13.56 MHz frequency.


Certain plasma processing applications and/or workpieces such as wafers advantageously allow charged species (e.g., ions and free electrons) within plasma products to come freely into contact with a workpiece, while other applications or workpieces advantageously reduce or isolate charged species from the workpiece. For example, adjustments in the ion concentration of the gas mixture can significantly alter its etch selectivity, e.g., SiNx:SiOx etch ratios, Si:SiOx etch ratios, etc. In alternative embodiments in which deposition is performed, it can also shift the balance of conformal-to-flowable style depositions for dielectric materials. For example, to reduce or isolate the charged species, a plasma may generate plasma products in a region that is upstream of a process chamber. The plasma is contained to the region where it is generated, and charged species are encouraged to neutralize and/or combine with one another, but neutral species such as uncharged molecular fragments, free atoms and excited but neutral radicals are allowed to pass through to the process chamber.


One way to contain plasma and exclude charged species from particular regions of a plasma processing system is to use an electrode that forms apertures through which neutral species and radicals can pass, but which inhibits passage of ions and/or free electrons, and through which the electric fields that generate the plasma are reduced. For example, FIG. 3 schematically illustrates a portion of a faceplate 217-1 (e.g., an example of faceplate 217, FIG. 2) that forms multiple apertures 259. The general concept of using aperture widths to selectively contain or allow passage of ionic species and/or free electrons is now discussed using faceplate 217-1 as an example. However, it should be clear that the principles taught can pertain to other parts of a plasma processing system where a plasma is generated in one location and transmitted through an electrode to another location, or where a plasma is generated in a location of intended use and apertures are used to limit backstreaming of ionic species and free electrons to unintended locations.


Each aperture 259 forms a narrow passageway about halfway through faceplate 217-1 between points A-A, as shown. The width of apertures 259 between points A-A can be such that the electromagnetic power that generates and/or sustains the plasma above faceplate 217-1 (e.g., in first plasma generation chamber 215, FIG. 2) is strongly attenuated within apertures 259, and ionic species and free electrons are forced through collisions and other wall effects to recombine and/or neutralize one another. A width of apertures 259 that will limit passage of ionic species and free electrons is related to the Debye length of the plasma, and can be calculated based on factors such as a wavelength of the electromagnetic power generating the plasma, the gas species from which the plasma is formed, and pressure of the plasma. It should also be noted that complete segregation of ionically charged species may not be desired in all embodiments. For example, in certain instances, some ionic species are intended to reach a processing region in order to perform an etch and/or deposition process. In these instances, apertures 259 of electrodes such as faceplate 217-1 may be sized so as to merely reduce, but not eliminate, ionic species in the processing region. Other factors may also influence an optimum width of apertures 259, such as material properties of faceplate 217-1 and/or coatings thereon. Thus, determination of width of apertures 259 for a given type of plasma system is usually determined empirically. An adjustable electrical bias may also be applied to faceplate 217-1 as an additional means to control the flow of ionic species through the faceplate.


It should be understood that apertures 259 are formed in faceplate 217-1 across an entire working area of the faceplate (e.g., working area 251, FIG. 2) and that a distance between faceplate 217-1 (or any other electrode herein having numerous apertures for plasma products to pass through) and workpiece 255 is great enough, as compared with spacing of apertures 259, for the plasma products to mix uniformly by the time they reach workpiece 255.


By using apertures 259 with narrow passageways, a process chamber may be configured to inhibit plasma, free electrons and/or ionic species from contact with a workpiece being processed. This may advantageously protect a variety of intricate structures and films patterned on the substrate, which could be warped, dislocated, or otherwise damaged if directly contacted by a plasma. Additionally, when plasma is allowed to contact or approach the workpiece, the rate at which oxide species etch may increase. Accordingly, if an exposed region of material is oxide, the material may be further protected by maintaining the plasma remotely from the substrate.


The principle of utilizing small apertures to contain plasma and suppress the flow of charged species can be applied to any electrode such as faceplate 217, ion suppressor 223 and/or showerhead 225, between a plasma generation region and a processing region, or between plasma generated in a processing region, and upstream regions. However, use of this principle can result in certain costs and constraints. Apertures 259 are generally formed by drilling in order to control the narrow passageway widths, and many such apertures are typically needed to provide enough plasma product throughput to maintain process reaction rates (e.g., etch or deposition rates) high enough for satisfactory workpiece throughput. Apertures 259 must also be very consistent in size, because process deviations may occur if certain spatial regions of an electrode have apertures 259 that are narrower or wider than in other spatial regions. To meet these needs, drilling alone can amount to thousands of dollars of labor and/or equipment time invested per electrode.


It is also very difficult to coat narrow apertures 259 uniformly with protective coatings (for example, yttria or alumina) to protect the electrode through which the apertures are formed. The high aspect ratio of apertures 259, particularly in the narrowest regions, tends to cause nonuniform coating thickness, and limits coating thicknesses that can be applied, because most coating techniques are directional. That is, the coating material tends to stick to the first object that it encounters. Typical coating techniques for applying yttria or alumina on aluminum parts include plasma spraying and atomic layer deposition. Plasma spraying is moderately precise and moderately expensive, while atomic layer deposition is extremely precise and extremely expensive; both techniques are at least somewhat directional. Thus, with either technique, coating tends to build up readily on flat plates, and much slower within passageways that are substantially parallel with the direction along which the coating material travels during deposition. Atomic layer deposition provides good control over thickness, even within apertures 259, but plasma spraying that is sufficient to coat far within apertures 259 can build up at the outer edges of the apertures, resulting in size variation among the apertures.


Still furthermore, when the area of an electrode that permits passage of plasma products is constricted by forming very small apertures therethrough, the flow of the plasma products is necessarily reduced, which slows down the desired processes such as deposition and etching. Additionally, once apertures 259 of the size and number required are formed, they cannot be readily changed; if a different aperture size is required to support a different process or a desired change of process parameters, an entire electrode must be removed and replaced with a different one. Opening up a process chamber is generally undesirable in plasma processing equipment, because electrode surfaces are generally exposed only to tightly controlled conditions and/or substances during use; opening the chamber to atmosphere usually disrupts chamber surface conditioning, resulting in a need to recondition the surfaces and test chamber performance before production processing is allowed to resume.


Certain embodiments herein provide plasma containment and ion suppression by utilizing a plurality of electrodes with apertures therethrough, wherein the apertures can be of almost any size, but whose alignment or misalignment with respect to one another is controlled, and wherein the electrodes are maintained in extremely close proximity to one another. In these embodiments, a gap between the electrodes can play the same role as the narrow passageways of apertures 259 described above. While this approach results in new constraints, such as needs for electrode planarity and gap distance control, most or all of the constraints noted above are mitigated or eliminated. For example, drilling costs for the electrodes can be reduced because electrode apertures can be fewer and larger; coating difficulties for the electrodes can be reduced because electrode aperture aspect ratios are decreased, and available area for throughput of plasma products can be increased. Also, through the use of appropriate mechanisms as described below, electrode gap distance and/or aperture alignment can be adjusted to provide process effects. One result of this is that gap distance and/or aperture alignment can be changed substantially, in situ, from time to time so that different processes can be performed without removing and replacing electrodes or using multiple pieces of process equipment.



FIG. 4 schematically illustrates a portion of a two part electrode assembly 325-1 that includes individual electrodes 326-1 and 326-2, in a cross-sectional view. The principles now described in connection with FIG. 4 can be applied, in embodiments, to any electrode or set of electrodes that separate portions of a plasma system, such as separating a plasma generation region from a process chamber and/or from other electrodes. For example, two part assembly 325-1 could take the place of ion suppressor 223 and/or showerhead 225, FIG. 2. One of ordinary skill in the art would immediately conceive of many alternatives, variations and/or equivalents, all of which are considered within the scope of this disclosure. Electrodes 326-1 and 326-2 may be fixedly coupled with one another or may be movable with respect to one another, as discussed further below. Electrodes 326-1 and 326-2 are typically held at a common electrical potential, for example by connecting them through an optional RF grounding strap 319.


Each of electrodes 326-1 and 326-2 forms many apertures 329-1, 329-2 respectively, in the illustrated plane of FIG. 4, but are continuous in other planes, such that the pieces illustrated in FIG. 4 are but parts of each electrode 326-1 and 326-2. Each aperture 329-1 has a diameter D1, and each aperture 329-2 has a diameter D2. FIG. 4 shows D1 and D2 as approximately equal, but this is not required, and it is not required that D1 or D2 be the same across all apertures of either electrode. In certain embodiments, nominally similar diameters across each electrode advantageously provide ease of layout and drilling efficiency. Electrode 326-1 defines a first planar surface 301 and a second planar surface 302 separated by an electrode thickness T1; electrode 326-2 defines a third planar surface 303 and a fourth planar surface 304 separated by an electrode thickness T2. FIG. 4 shows T1 and T2 as approximately equal, as found in certain embodiments, but this, is not required. In practice, T1 and T2 are typically chosen based on the lateral dimensions of electrodes 326-1 and 326-2 and based on the electrode material(s), such that the electrodes are mechanically stable across an intended process chamber, but advantageously not much greater than needed to ensure mechanical stability, for reduced weight and material cost. For example, in certain embodiments, T1 and T2 are about one quarter inch (e.g., 4 to 8 mm) for a plasma processing system that processes 12 inch (300 mm) nominal wafers, but in other embodiments of other sizes or having other constraints, T1 and T2 could range from 0.100 inch to about 1.00 inch (e.g., 2 to 25 mm). In certain embodiments, D1 and D2 are chosen so that an aspect ratio T/D of apertures 329-1, 329-2 is about 2:1 or less, to promote uniform application of coatings within the apertures. However, other embodiments use apertures with aspect ratios greater than 2:1, particularly when techniques such as chamfering are used to make inside walls of the apertures more accessible for application of coatings (see FIG. 5).


Apertures 329-1 and 329-2 are arranged or are at least adjustable so that no line-of-sight from above assembly 325 to below assembly 325 exists through any pair of apertures 329-1 and 329-2. Thus, when a plasma or gas exists above assembly 325, individual species such as ions, molecular fragments, individual atoms or free electrons can only pass through assembly 325 by passing first through an aperture 329-1, then between electrodes 326-1 and 326-2, then through an aperture 329-2. Electrodes 326-1 and 326-2 are separated by a gap of distance G between surfaces 302 and 303, as shown. G can be chosen so as to contain plasma and suppress the flow of charged species, from above assembly 325, to below it.


The value of gap distance G that will accomplish these objectives is a function of plasma source gas type, plasma pressure, power density applied to the plasma, and aperture-to-aperture registration. For charged species containment, gap distance G should be about, or smaller than, the minimum aperture size that would support a hollow-cathode discharge. Thus, typical values of gap distance G to contain plasma are generally on the order of 0.002 inches to 0.150 inches (e.g., about 0.05 mm to 3.81 mm). Higher pressures and power densities will promote the possibility of plasma “leakage” (e.g., passage of charged species through the two electrode assembly), other variables being equal. For example, useful upper bounds for gap distance G may be about 0.045 inch and 0.035 inch for certain source gases and power densities at 10 and 20 Torr respectively, but G could vary further for higher or lower pressures, or due to other variables. Because of all the variables involved, an upper end of gap distance G that will contain charged species may be any of 0.002 inches, 0.005 inches, 0.010 inches, 0.015 inches, 0.020 inches, 0.025 inches, 0.030 inches, 0.035 inches, 0.036 inches, 0.040 inches, 0.045 inches, 0.048 inches, 0.050 inches, 0.055 inches, 0.060 inches, 0.065 inches, 0.070 inches, 0.075 inches, 0.080 inches, 0.085 inches, 0.090 inches, 0.095 inches, 0.100 inches, 0.105 inches, 0.110 inches, 0.115 inches, 0.120 inches, 0.125 inches, 0.130 inches, 0.135 inches, 0.140 inches, 0.145 inches or 0.150 inches, or values intermediate to those listed. Lower bounds of G can be set based on known or estimated planarity variations of the electrodes, and built-in offsets for gap distance calibration purposes, such as described below. Lower bounds of G for certain embodiments are 0.005 to 0.010 inches.


In certain embodiments, electrodes 326-1 and 326-2, and thus apertures 329-1 and 329-2, are fixed with respect to one another. In other embodiments, at least one of electrodes 326-1 and 326-2 is adjustable with respect to the other, so that for at least one position with any applicable ranges of adjustment (as discussed below), a lateral distance between any aperture 329-1 and a nearest aperture 329-2 is at least two or at least three times G. By increasing the probability of charged species interacting with surfaces of at least one of electrodes 326-1 and 326-2, these lateral distances advantageously minimize any tendency for ionized species or free electrons to move from above assembly 325, through apertures 329-1 and 329-2 that are close to one another, to below assembly 325. However, a combination of small gap distance G (e.g., less than about 0.005 or 0.010 inches) and/or large lateral distances (e.g., more than three times G) may also reduce passage of neutral radicals and atomic species. Considering all of the effects, certain useful values of G to contain charged species but allow neutral species passage are:

    • Gap distance G between 0.005 to 0.035 inches and lateral distance between apertures at least twice gap distance G; especially for (but not limited to) plasmas operating at or around 20 Torr pressure; and
    • Gap distance G between 0.010 to 0.045 inches and lateral distance between apertures at least twice gap distance G; especially for (but not limited to) plasmas operating at or around 10 Torr pressure.


Also, as described further below, gap distance G between electrodes 326-1 and 326-2 may be intentionally varied from a plasma-containing gap distance to a larger distance that allows plasma leakage, to tailor processing characteristics. The gap distance G can control both whether leakage exists at all, and the amount of leakage, thus providing a mechanism for controlling a ratio between neutral and charged species passing through a two electrode assembly.



FIG. 5 schematically illustrates a portion of another two part assembly 325-2 that includes individual electrodes 326-3 and 326-4, in a cross-sectional view. Assembly 325-2 differs from assembly 325-1 by the diameters of apertures 329-3, 329-4 through electrodes 326-3 and 326-4 respectively being different from diameters of apertures 329-1, 329-2 through electrodes 326-1 and 326-2 (FIG. 4) and by apertures 329-4 forming chamfered edges 328, as shown. Chamfered edges 328 help to improve coating uniformity within apertures 329-4 when diameter


D4 is substantially smaller than a thickness of electrode 326-4, resulting in a high aspect ratio.


In certain embodiments, electrodes 326 are coupled fixedly with respect to one another and/or other plasma chamber components. These embodiments can be both less expensive to manufacture, and more durable, than systems with electrodes having very small apertures for ion and free electron control. The reduced cost is due to reduced drilling cost and reduced coating cost, while the durability can be improved by applying thicker coatings using plasma spraying, as opposed to atomic layer deposition. Electrodes 326 can also support higher plasma processing rates, because they provide freer passage of desired (neutral) plasma products, while blocking the components that are less desirable for certain processes, such as ions and free electrons.



FIG. 6A schematically illustrates a two part electrode assembly 325-3 that includes two electrodes 326-5 and 326-6 and an adjustable coupler, in a cross-sectional view. FIG. 6A is shown in two portions with a break in between, to allow features on either side to be shown in greater detail. A portion within FIG. 6A identified as 6B is enlarged in FIG. 6B.


In FIG. 6A, the adjustable coupler is a height actuator 330, which is operable through electronic input to adjust gap G between electrodes 326-5 and 326-6. As used herein, “actuators” refer to adjustable couplers that can move or reposition one object with respect to another in response to electronic input, while other adjustable couplers may be adjusted manually or with hand tools. A support portion 335 provides a mechanical reference and support for assembly 325-3; lower electrode 326-6 is coupled fixedly with support portion 335. Support portion 335 is, for example, a base or a housing of a plasma processing system. Upper electrode 326-5 couples both with height actuator 330 and with a suspension mechanism 340. Suspension mechanism 340 is represented by coil springs in FIG. 6A, although other suspension mechanisms are possible, such as for example leaf springs, or pneumatic systems. In the illustrated embodiment, suspension mechanism 340 transfers at least most of the weight of upper electrode 326-5 to support portion 335, to reduce mechanical demands on height actuator 330, and to possibly improve precision of height control provided by height actuator 330. Suspension mechanism 340 is optional, however, and is not included in certain embodiments.


Height actuator 330 is operable to adjust gap G between surface 302 of electrode 326-5 and surface 303 of 326-6. Height actuator 330 is a stepper motor in embodiments, although other height actuators may be used, such as other types of motors, solenoids, piezoelectric actuators and the like. Stepper motors are advantageous height actuators because they can be controlled electronically and can provide fine height control in response to such control. In the embodiment illustrated in FIG. 6A, height actuator 330 couples with a ring 345 (see also FIGS. 7, 8) that connects, via rods 350, to upper electrode 326-5.


Other members and/or mechanisms may be used to couple an actuator with an electrode. Similarly, an upper electrode of a two piece electrode assembly may be fixed (e.g., to a base or housing) while the lower electrode is adjustable. One of ordinary skill in the art would immediately conceive of many alternatives, variations and/or equivalents, all of which are considered within the scope of this disclosure.



FIG. 6B schematically illustrates the portion within FIG. 6A noted as 6B, in an enlarged view. As shown in FIG. 6A, rod 350 connects with upper electrode 326-5, this enables height actuator 330 to adjust gap G. Lower electrode 326-6 includes an optional region 360 that forms a slight protrusion with respect to surface 303. This allows region 360 to be used as a mechanical stop to establish a zero position or height reference between electrodes 326-5 and 326-6 without bringing surfaces 302 and 303 into direct contact with one another. In one way of establishing a height reference, height actuator 330 can be operated until surface 302 is in contact with region 360, and a position of height actuator 330 when surface 302 is in contact with region 360 can be designated the zero position or reference height for height actuator 330. For example, a controller can provide electronic input to a stepper motor acting as height actuator 330 until surface 302 is in contact with region 360, the electronic input can be released with the electrodes in contact, the electronic input can be reestablished at the position of contact, and height adjustments can be made by backing off the stepper motor by a known number of steps. Alternatively, an electronic input value that brings the electrodes into contact can be stored as a zero value, and height adjustments can be made by varying the electronic input relative to the stored value. Thereafter, since the distance response of the stepper motor to a given number of steps is known, height actuator 330 can be operated so as to increase gap G by a known amount with respect to the reference height. Using region 360 to establish contact between first and second electrodes 326-5, 326-6 in this manner allows calibration of gap G while avoiding face-to-face contact of surfaces 302 and 303. This, in turn, minimizes the chance of accidental damage resulting from contact between surfaces 302 and 303, or at least moves the point of contact away from the center of electrodes 326-5 and 326-6, where any damage is more likely to affect workpiece (e.g., wafer) processing. A height of region 360 relative to its adjacent surface (e.g., surface 303 in FIG. 6B) is advantageously greater than anticipated planarity variations of surfaces 302 and 303, but less than a height that would begin to allow ionized species through a gap formed between surfaces 302 and 303 when region 360 contacts the opposing surface. In certain embodiments, a height of region 360 relative to its adjacent surface is 0.005 inch or less, with estimated planarity variations of surfaces 302 and 303 (combined) being about 0.004 inch, and an estimated gap distance above which ionized species could begin to leak through the gap being about 0.010 inch. Although region 360 is shown as a protrusion with respect to surface 303, it is understood that region 360 could be implemented as a protrusion with respect to surface 302, or protrusions with respect to both surfaces 302 and 303. FIG. 6B also illustrates a bellows 355 that surrounds rod 350; bellows 355 isolates rod 350 and its surrounding mechanical features from adjacent areas in order to exclude any particles or debris generated by moving parts associated with actuator 330, suspension mechanism 340 and the like.



FIG. 7 schematically illustrates a two piece electrode assembly with two actuators for adjusting vertical position of one electrode with respect to another electrode, in a cross-sectional view. The assembly shown in FIG. 7 is the same as that shown in FIGS. 6A and 6B, except that two height actuators 330-1 and 330-2 adjust height of ring 345, connected with lower electrode 326-6, at different locations around a circumference of ring 345. In this embodiment, coupling points between height actuators 330-1 and 330-2, and ring 345 and/or support portion 335, are nonrigid so that a mechanical system thus formed is not overconstrained, that is, one or both coupling points may form angles necessary for ring 345 to be at one height at height actuator 330-1, and another height at height actuator 330-2, relative to support portion 335. By providing height adjustment at two points around ring 345, gap G can be adjusted to be greater on one side than the other, forming a tilt. The azimuthal tilt axis between electrodes 326-5 and 326-6 (e.g., a direction from one peripheral point where gap G is greatest, to another peripheral point where gap G is smallest) would align with the coupling points of ring 345 with electrodes 326-5 and 326-6. Mechanical stops (e.g., protrusions like protrusion 360, FIG. 6B) can be provided adjacent to each height actuator 330-1, 330-2 so that reference heights for actuators 330-1, 330-2 can be set independently of one another.


One skilled in the art can see that a further extension of the approach illustrated in FIG. 7, but including three actuators with coupling points spaced around ring 345, could set an azimuthal tilt axis of a gap thus formed to any direction, by coordinating height of all three height actuators. Also, actuators that control lateral position of electrodes are also possible. FIG. 8 schematically illustrates an assembly with six actuators for adjusting lateral and vertical positions of a ring 345 with respect to a support portion 335, in a plan view. Support portion 335 is for example a base or a housing of a plasma processing system, such as shown in FIGS. 6A and 7. In FIG. 8, a vertical direction, shown in FIGS. 2-7 as vertical in the drawings, is in and out of the page, while directions 311 and 312 are horizontal directions.


Ring 345 can be used to position one electrode of a two piece electrode assembly, where the other electrode of the two piece electrode assembly is fixedly coupled with support portion 335. An underside of ring 345 couples with one of the two electrodes, which are hidden by ring 345 and other structures in the plan view of FIG. 8. Three height actuators 330-3, 330-4 and 330-5 couple with ring 345 so that a gap G between the two electrodes can be adjusted and so that the gap can be formed along any desired azimuthal tilt angle. Coupling points between height actuators 330-3, 330-4 and 330-5 and ring 345 and/or support portion 335, are nonrigid so that a mechanical system thus formed is not overconstrained. Although FIG. 8 shows height actuators 330-3, 330-4 and 330-5 and ring 345 as spaced approximately equidistant around ring 345, it is understood that equal spacing is not required. As discussed above, various embodiments may include only one, two, or all three of height actuators 330-3, 330-4 and 330-5, and height actuators 330-3, 330-4 and 330-5 can all be considered examples of adjustable couplers that could also be operated manually or using hand tools.


A first horizontal actuator 330-6 and a second horizontal actuator 330-7 are operable to position height actuator 330-3 and ring 345 in different horizontal directions relative to support portion 335. A third horizontal actuator 330-8 is operable to position ring 345 rotationally with respect to support portion 335. Coupling points between horizontal actuators 330-6, 330-7 and 330-8 and ring 345 and/or support portion 335, are also nonrigid so that a mechanical system thus formed is not overconstrained (e.g., the combined actions of height actuators 330-6, 330-7 and 330-8 do not twist or deform ring 345). Various embodiments may include only one, two, or all three of horizontal actuators 330-6, 330-7 and 330-8, and horizontal actuators 330-6, 330-7 and 330-8 can all be considered examples of adjustable couplers that could also be operated manually or using hand tools. Any or all of height actuators 330-3, 330-4 and 330-5, horizontal actuators 330-6, 330-7 and 330-8, ring 345 support portion 335 and/or electrodes positioned thereby may be held at a common electrical potential by connecting them through optional RF grounding straps 319, as illustrated in FIG. 8. Also, mechanical stops may be used to set reference values for each of horizontal actuators 330-6, 330-7 and 330-8 (e.g., in the same manner as region 360 can be used to set a reference value for height actuator 330; see FIG. 6B).


Thus, horizontal actuators 330-6, 330-7 and 330-8 are collectively capable of positioning ring 345 and an electrode that ring 345 couples with, along any of horizontal directions 311 and 312, and rotational direction 313 relative to a central axis 314 of ring 345, as shown, within an adjustment range of each of horizontal actuators 330-6, 330-7 and 330-8.


The ability to control both lateral and vertical spacing of electrodes in a plasma processing system provides advantages not previously available in such systems. First, effects of height actuators 330-1, 330-2 and/or 330-3 are considered. When the overall gap distance is sufficiently small, a lateral spacing of about three times the gap distance is believed sufficient to ensure neutralization of free electrons and ions, given that there may be a small subset of free electrons and/or ions that find their way from one aperture, through the gap and to another aperture, through collisions. When gap spacing is large, free electrons and/or ions will move through freely. An exact distance sufficient to allow free passage of free electrons and/or ions is related to an effective Debye length of the applicable plasma, but for practical purposes this distance is determined by process characterization. One height actuator 330 is sufficient to adjust the gap distance G globally; two height actuators 330 enable the gap distance to be tilted along one azimuthal direction (defined by a line between attachment points of the actuators with the movable electrode); and three height actuators 330 enable a tilt to be worked into the gap distance along any azimuthal direction. This can be used to shift processing from domination by neutral species chemistry to ionic chemistry and vice versa, and can provide a process control bias from one side of the system to the other.


Next, effects of horizontal actuators 330-6, 330-7 and 330-8 are considered. In certain embodiments, adjustment ranges of one or more of horizontal actuators 330-6, 330-7 and 330-8 are sufficient to move apertures 329 of electrodes 326 relative to one another, sufficiently to modify the ability of the two piece electrode apparatus to permit or inhibit throughput of certain plasma products. That is, within the adjustment ranges of horizontal actuators 330-6, 330-7 and/or 330-8, certain positions may correspond to apertures 329 being out of alignment, so that no apertures 329 in one of the electrodes 326 align with any of apertures 329 in the other electrode 326, to form an open straight-line path extending through both of the electrodes. Adjusted in this manner, free electrons and ionic species tend to contact, and be neutralized by, one or the other of electrodes 326. In addition to not forming an open straight-line path, these positions may meet the condition that apertures 329 in one of the electrodes 326 are laterally positioned at least three times the local gap distance from apertures 329 in the other electrode 326. That is, adjacent to each aperture 329 in one electrode, the gap is bounded by electrode material, not an aperture, for least three times the gap distance from any aperture 329 in the other electrode 326, measured laterally in any direction.


When two electrodes are provided with similar aperture layouts, translation of one electrode relative to another can bring apertures 329 on one electrode into, or out of, horizontal proximity or alignment with apertures 329 on the other electrode, all at the same time. Bringing all of the apertures into alignment at the same time (e.g., see FIGS. 9C, 10B) allows selective admittance or inhibition of free electrons and/or ions across the entire working area of a processing system (e.g., working area 251 of plasma processing system 200, FIG. 2). Rotation of one electrode with respect to the other can cause very different effects. Radially symmetric layouts can, when one electrode is rotated relative to another, cause apertures far away from the center of rotation to come into alignment (e.g., see FIG. 12) with areas where the apertures are aligned moving closer to the center for as rotation is increased. This can be utilized to modify processing by creating process effects related to radial position within the working area. Layouts with different (e.g., non-radial) symmetry can generate other patterns of overlap or non-overlap of aperture areas. All such patterns can be used to provide degrees of process control by regulating throughput of free electrons and/or ions relative to throughput of unionized plasma species, across the two piece electrode assembly. The possible variations of such throughput regulation are thought to be more diverse than achievable with previous electrode assemblies; some such variations, and how they are achieved, are discussed in detail below.



FIG. 9A schematically illustrates a layout 401 of apertures 329-5 that could be formed in an electrode of a two piece electrode assembly, in a plan view. Apertures 329-5 are not drawn to any particular scale, but are uniform in size and layout with respect to one another, as illustrated. Layout 401 is a rectangular arrangement; it should be understood that layout 401 could be continued throughout a working area of an electrode (e.g., see working area 251, FIG. 2). FIG. 9B schematically illustrates a layout 402 that includes apertures 329-5 as in layout 401, and apertures 329-6 of a second electrode, also in a rectangular arrangement, and interspersed with apertures 329-5. Apertures 329-6 are also not drawn to any particular scale but are uniform in size and layout with respect to one another and with respect to apertures 329-5, as illustrated. Apertures 329-5 could be formed within an upper of two electrodes with apertures 329-6 formed within a lower of the two electrodes, or vice versa. Like faceplate 217-1 discussed above (FIG. 2), it should be understood that apertures 329-6 in layout 402 could be continued across an entire working area of an electrode. Also like faceplate 217-1, a distance between the electrodes that form apertures 329-5 and 329-6 and a workpiece to be processed is great enough, as compared with spacing of apertures 329-5 and 329-6, for plasma products to mix uniformly by the time they reach the substrate.



FIG. 9C schematically illustrates layout 402′ that includes apertures 329-5 laid out in the same arrangement relative to one another as in layouts 401 and 402, and apertures 329-6 laid out in the same arrangement relative to one another as in layout 402. However, in layout 402′, all apertures 329-6 are shifted relative to apertures 329-5, as would occur if one electrode forming apertures 329-6 were shifted laterally relative to another electrode forming apertures 329-5 (e.g., using horizontal actuators 330-6 and 330-7, FIG. 8). In FIG. 9C, it can be seen that each aperture 329-5 overlaps a corresponding aperture 329-6 by the same amount as each other aperture 329-5 overlaps a corresponding aperture 329-6. This illustrates that when two electrodes have apertures in identical arrangements, shifting one electrode laterally relative to the other electrode can be utilized to bring apertures into alignment across an entire working area of the electrode simultaneously. Because each overlapping pair of apertures 329-5, 329-6 is at the same spacing as either of apertures 329-5 and/or 329-6, plasma products such as free electrons or ions can pass at locations that are at the same spacing as the apertures themselves. Thus, the ionized plasma products can mix uniformly by the time they reach a workpiece being processed. The ability to move one electrode relative to another, and to use a gap between the electrodes to prevent ionized plasma products from moving through except where apertures overlap, creates the ability to selectively gate the ionized plasma products, without changing plasma generation conditions and without changing out electrodes to replace small diameter apertures with larger apertures.


Other layout strategies for apertures on two electrodes are possible and certain design tradeoffs are possible. For example, each of apertures 329-5 and 329-6 in layout 402 is relatively sparse in the sense that each electrode that forms the apertures is mostly solid, with only about 14% of the surface area removed to form apertures. This may allow for fine control of aperture overlap (e.g., relatively large electrode motions required to make apertures overlap, and relatively small increase of overlap area with further motion) but may reduce overall throughput of unionized species due to the low aperture area. The same layout, but using larger apertures, would increase overall throughput of unionized species but may decrease control of aperture overlap (e.g., relatively small electrode motions required to make apertures overlap, and relatively quick increase of overlap area with further motion).



FIG. 10A schematically illustrates a layout 403 of apertures 329-5, 329-6 in hexagonal arrangements that can be formed in each of an upper and a lower electrode. In layout 403, apertures 329-6 are located horizontally adjacent to apertures 329-5 in the orientation of FIG. 10A, but this need not necessarily be the case; apertures 329-6 could be formed with vertical offsets, horizontal offsets or both relative to apertures 329-5. Also, in the arrangement shown in FIG. 10A, a horizontal movement of one electrode, in the orientation of the drawing, would result in overlap between apertures 329-5 and 329-6 with a smaller movement than a vertical movement of the electrode in the orientation of the drawing.



FIG. 10B schematically illustrates a layout 403′ of apertures 329-5, 329-6 in the hexagonal arrangements shown in FIG. 10A, but shifted such that a small overlap occurs between each pair of apertures 329-5, 329-6. It can be seen that, in the orientation of FIG. 10B, if apertures 329-5 are shifted further in the horizontal direction, overlap between pairs of apertures 329-5, 329-6 will increase or decrease quickly, but if apertures 329-5 are shifted in the vertical direction, overlap between pairs of apertures 329-5, 329-6 will increase or decrease slowly. This demonstrates that, for some layouts, sensitivity of overlap area to movement can be particular to the direction of movement, which can be used to provide relatively coarse and fine processing adjustments. That is, in the orientation of FIG. 10B, horizontal movements would provide coarse adjustments (i.e., relatively large changes of overlap area with respect to motion) while, after overlap is established, vertical movements would provide fine adjustments.



FIG. 11 schematically illustrates a layout 404 of apertures 329-7, 329-8 in a radial arrangement. It can be appreciated that care may be needed in radial layouts so that a ratio of aperture area to electrode area remains uniform at different radii, and so that distances between adjacent apertures 329 allow for placement of apertures on an opposing electrode without forming unintended overlaps in an initial position of the electrodes It may be advantageous to form apertures 329 of differing sizes depending on their location within a layout; note that apertures 329-8 are illustrated as smaller than apertures 329-7.


Rotation of electrodes can have a variety of effects on aperture alignment that can depend on initial aperture layout, size, spacing, and positioning relative to axis of the rotation. For example, FIG. 12 schematically illustrates a layout 405 in which one set of apertures 329-6 has been rotated by 5 degrees relative to another set of apertures 329-5. The choice of a 5 degree rotation is for illustrative purposes only; in general, rotations used to generate overlap or non-overlap of apertures will be smaller, for reasons explained more fully below. Axis 314 is shown in layout 405, and is selected such that apertures 329-5 and 329-6 are arranged symmetrically about axis 314 in both the horizontal and vertical directions, in the orientation of FIG. 12. Because of this symmetry, similarly placed ones of apertures 329-5 and 329-6 are at about the same radii from axis 314 as one another. It can be seen that overlap among apertures 329-5 and 329-6 varies uniformly by radius from a large overlap near axis 314 to a small overlap at edges of layout 405. In corners of layout 405 where apertures 329-5 and 329-6 are furthest from axis 314, the overlap disappears entirely. It can be appreciated that larger apertures 329-5 and 329-6 might mitigate the change in amount of overlap across layout 405 as shown, that is, larger apertures at the same locations would overlap more, even out to edges of layout 405. However, it can also be appreciated that if layout 405 represents apertures formed in only part of an electrode, that beyond the apertures shown, rows and columns of apertures 329-5 will begin to overlap with apertures 329-6 in different rows and columns. This can bring about radial effects (e.g., moire patterns) such as regions where apertures overlap, then regions where apertures do not overlap, then regions where apertures overlap again, and so on, as radius from axis 314 increases.


In another example, FIG. 13 schematically illustrates a layout 406 in which, again, one set of apertures 329-6 has been rotated by 5 degrees relative to another set of apertures 329-5. Axis 314 is shown in layout 406, and this time is selected such that apertures 329-6 are arranged symmetrically about axis 314 in both the horizontal and vertical directions, in the orientation of FIG. 12; however, one row of apertures 329-5 are aligned with axis 314, but axis 314 falls between adjacent columns of apertures 329-5. Because of this arrangement, rows and columns of apertures 329-6 move from misalignment to alignment with respect to rows and columns of apertures 329-5 in a way that is not radially dependent, as in layout 405. In regions bounded by broken lines 420 on either side of layout 406, some overlap exists between apertures 329-5 and 329-6. It can be seen that if extended through large arrays of apertures 329-5 and 329-6, regions would exist where different rows and/or columns of apertures 329-5 and 329-6 would overlap. In certain embodiments, this effect can be used to generate accordingly asymmetric process effects. However, these would be unusual cases. More importantly, it can be seen that these effects tend to form an upper limit on useful values of rotation that depend on size, spacing and arrangement of apertures 329.


Two piece electrode assemblies can be used to enable several new methods of providing plasma products, or operating or optimizing plasma apparatus, a few examples of which are now discussed. FIG. 14 is a schematic diagram illustrating major components of a plasma processing system 450 for reference to such components in the method descriptions that follow; additional components illustrated in other drawings herein may also be referred to in the method descriptions. System 450 includes a housing 445 to which other components of system 450 are directly or indirectly coupled. That is, housing 445 can serve as a support portion for other components of system 450, like support portion 335, FIGS. 6A, 7. System 450 includes a plasma generation region 215 that is operable to produce a plasma 230. Plasma generation region 215 may be a chamber having substantially the same width as housing 445 (e.g., like first plasma generation region 215, FIG. 2), or may be a smaller chamber or remote plasma system (e.g., like remote plasma system 201, FIG. 2). Plasma generation region 215 is in fluid communication with a downstream chamber 333 that may be a process chamber (e.g., containing pedestal 265 to support workpiece 255) or may be an intermediate chamber, with a process chamber located further downstream. Two-piece electrode assembly 325, here shown with electrodes 326-7 and 326-8, is capable of modifying the fluid communication between plasma generation region 215 and downstream chamber 333. For example, when electrodes 326-7 and 326-8 are positioned in close proximity with one another (e.g., with gap G therebetween in the range of 0.005 inch to 0.050 inch, and apertures within electrodes 326-7 and 326-8 do not overlap, electrodes 326-7 and 326-8 will keep plasma 230 (if present) within plasma generation region 215, and will prevent most free electrons and/or ions from passing through to downstream chamber 333. However, if actuators or adjustable couplers (not shown in FIG. 14, see FIGS. 6A, 7, 8) move either of electrodes 326-7 and 326-8 relative to one another so as to open up gap G, or cause apertures of electrodes 326-7 and 326-8 to align or nearly align (e.g., come within about three times the amount of gap G from alignment) then plasma, free electrons and/or ionic species may be allowed to pass from plasma generation region 215 to downstream chamber 333. Thus, if plasma products that pass from plasma generation region 215 to downstream chamber 333 are called a first portion at a first time, and are called a second portion at a second time after the relative positions of electrodes 326-7 and 326-8 change, the difference between the first position and the second position causes two piece electrode assembly 325 to modify a proportion of ionized species to neutral species in the second portion relative to the first portion.



FIG. 15 is a flowchart of a method 500 for providing plasma products. In a first step 502, at least a portion of a source gas is converted to plasma products, by providing electromagnetic power to the source gas within a plasma generation chamber to generate a plasma. Examples of step 505 include operating remote plasma system 201, FIG. 2, to supply plasma products through gas inlet assembly 205; generating a plasma 216 within first plasma generation chamber 215; or operating plasma system 450, FIG. 14, to generate a plasma 230 within plasma generation chamber 215. A second step 504 passes at least a portion of the plasma products through a two piece electrode assembly. The two piece electrode assembly is understood to include electrodes 326 arranged as disclosed herein. That is, a first one of the electrodes defines a plurality of first apertures therethrough, a first side of the first electrode facing the plasma such that the portion of the plasma products passes through the plurality of first apertures to a second planar side of the first planar electrode Examples of the first electrode include electrodes 326-1, FIG. 4; 326-3, FIG. 5; 326-5, FIGS. 6A, 6B and 7; and 326-7, FIG. 14. A second one of the electrodes defines a plurality of second apertures therethrough, a third planar side of the second electrode being disposed facing the second side of the first electrode. The second electrode is coupled with the first electrode such that the third planar surface is disposed adjacent to the second planar surface, with a gap distance G therebetween. The first and second apertures are arranged within the first and second electrodes such that none of the first apertures aligns with any of the second apertures to form an open straight-line path extending through both the first and second electrodes. The gap distance G is sufficient to allow neutral species of the plasma products to pass through the gap as the first portion of the plasma products, but is sufficiently small to cause ionized species of the plasma products to interact with the first or second electrodes and not to pass through the two piece electrode assembly. Examples of the second electrode include electrodes 326-2, FIG. 4; 326-4, FIG. 5; 326-6, FIGS. 6A, 6B and 7; and 326-8, FIG. 14. An example of a gap distance G that is sufficient to allow neutral species of the plasma products to pass through the gap as the first portion of the plasma products, but is sufficiently small to cause ionized species of the plasma products to interact with the first or second electrodes and not to pass through the two piece electrode assembly, is a gap distance G of 0.005 inch to 0.050 inch.



FIG. 16 is a flowchart of a method 510 for optimizing a plasma apparatus. A first step 512 provides a plasma generation chamber, a downstream chamber, and a two piece electrode assembly between the plasma generation chamber and the downstream chamber. The two piece electrode assembly is operable to modify fluid communication between the plasma generation chamber and the downstream chamber. An example of step 512 is providing plasma generation chamber 215 and downstream chamber 333, with two piece electrode assembly 325 between the two, as shown in FIG. 14. The first electrode defines a plurality of first apertures therethrough. A first surface of the first electrode faces the plasma generation chamber, and a second planar surface of the first electrode faces away from the plasma generation chamber. A second electrode defines a plurality of second apertures therethrough. A third planar surface of the second electrode faces the second planar surface of the first electrode, and a fourth surface of the second electrode faces the downstream chamber. Examples of the first and second electrodes include electrodes 326-1 and 326-2, FIG. 4; 326-3 and 326-4, FIG. 5; 326-5 and 326-6, FIGS. 6A, 6B and 7; and 326-7 and 326-8, FIG. 14. One or more actuators couple the first and second electrodes. The one or more actuators are operable, in response to an electronic input, to adjust a position of the first electrode relative to a position of the second electrode. Examples of the actuators are any of actuators 330 or 330-1 through 330-8, FIGS. 6A, 7 and 8. The one or more actuators can be operated to provide at least one position of the first electrode relative to the second electrode such that the third planar surface is disposed adjacent to the second planar surface, with a first gap distance between 0.005 inch and 0.050 inch therebetween, and the first and second apertures are arranged within the first and second electrodes such that none of the first apertures aligns with any of the second apertures to form an open straight-line path extending through both the first and second electrodes. A second step 514 of method 510 establishes a position of the first electrode at a first position relative to the position of the second electrode. An example of step 514 is establishing relative positions of electrodes 326-1 and 326-2, FIG. 4; 326-3 and 326-4, FIG. 5; 326-5 and 326-6, FIGS. 6A, 6B and 7; and 326-7 and 326-8, FIG. 14. Step 514 may, for example, operate any of actuators 330 or 330-1 through 330-8, FIGS. 6A, 7 and 8 to establish the relative positions. A third step 516 of method 510 operates the plasma generation chamber so as to flow at least a portion of plasma products generated thereby, through the two piece electrode assembly and into the downstream chamber, to process a workpiece. An example of step 516 is operating plasma system 450, FIG. 14, to generate a plasma 230 within plasma generation chamber 215, flowing at least a portion of plasma products generated thereby into downstream chamber 333, and processing workpiece 255.


A fourth step 518 of method 510 evaluates process results on the workpiece. Examples of step 518 include evaluating process results on the workpiece using any known method such as, but not limited to visual inspection, optical or mechanical measurements of layers or geometries formed therein, scanning electron microscope (SEM) or atomic force microscopy (AFM) based measurements, and/or electronic measurements, such as resistivity or other characteristics of circuit elements, or actual circuits, formed in or on the workpiece. Step 518 may also include further processing steps to place the workpiece in condition for measurement, such as stripping photoresist or otherwise preparing the workpiece for measurement by a particular instrument. Step 518 may also include evaluating the process results at multiple locations on the workpiece. A further step 520 operates the electronic input so as to modify the position of the first electrode to a second position relative to the position of the second electrode, in response to the process results. Examples of step 520 include operating electronic input to any of actuators 330 or 330-1 through 330-8, FIGS. 6A, 7 and 8, to reposition either the first or the second electrode. Optionally, steps 518 and 520 may be repeated until an optimal process point, that is, an optimal relative positioning of the first and second electrodes, is found.


Method 510 thus provides a process control mechanism that takes advantage of the fact that the two piece electrode assemblies discussed herein can change process conditions at the workpiece. For example, step 518 may reveal process results that should be changed across the entire workpiece. In this case, step 520 may reposition the first and/or second electrodes to allow a larger or smaller proportion of free electrons and/or ionic species everywhere, by increasing or decreasing the gap distance G, or by moving the first and second electrodes such that alignment between apertures on the first and second electrodes is affected across an entire working area of the electrodes (e.g., as in FIGS. 9C, 10B). In a special case, step 518 may reveal process results of more than one type, such as effects of an etch on different materials such as silicon dioxide, silicon nitride, polysilicon, one or more metals, photoresist, or the like, and/or specific geometries, such as bulk etch of a layer vs. the ability to clear remnants found in corners, trenches or the like. In this special case, step 520 may be repeated, and may reposition the first and/or second electrodes, first, to optimize one type of processing (e.g., an etch step on bulk material) and, second, to optimize a different type of processing (e.g., photoresist strip or an etch step to clear remnants).


In another example, step 518 may reveal process results that should be changed to provide, or eliminate, a bias across the workpiece. In this case, step 520 may reposition the first and/or second electrodes to change parallelism of the first and second electrodes, that is, to provide gap G with a tilt or gradient across the working area, as discussed above in connection with height actuators 330-3, 330-4 and 330-5. In yet another example, step 518 may reveal process results that should be changed to provide, or eliminate, a radial effect across the workpiece. In this case, step 520 may reposition the first and/or second electrodes to increase, or decrease, radial effects by increasing, or decreasing, overlap of apertures, as discussed above in connection with FIG. 12. These changes may be made alone, or with other changes to plasma conditions (e.g., input gas flows, pressure, RF power and the like). Also, steps 518 and 520 may optionally be repeated, as shown in FIG. 16 with dashed arrows.



FIG. 17 is a flowchart of a method 530 for optimizing a plasma apparatus. A first step 532 provides a plasma generation chamber, a downstream chamber, and a two piece electrode assembly between the plasma generation chamber and the downstream chamber. The two piece electrode assembly is operable to modify fluid communication between the plasma generation chamber and the downstream chamber. An example of step 532 is providing plasma generation chamber 215 and downstream chamber 333, with two piece electrode assembly 325 between the two, as shown in FIG. 14. The first electrode defines a plurality of first apertures therethrough. A first surface of the first electrode faces the plasma generation chamber, and a second planar surface of the first electrode faces away from the plasma generation chamber. A second electrode defines a plurality of second apertures therethrough. A third planar surface of the second electrode faces the second planar surface of the first electrode, and a fourth surface of the second electrode faces the downstream chamber. The first and second apertures are arranged within the first and second electrodes such that none of the first apertures aligns with any of the second apertures to form an open straight-line path extending through both the first and second electrodes. Examples of the first and second electrodes include electrodes 326-1 and 326-2, FIG. 4; 326-3 and 326-4, FIG. 5; 326-5 and 326-6, FIGS. 6A, 6B and 7; and 326-7 and 326-8, FIG. 14. An actuator couples the first and second electrodes. The actuator is operable, in response to an electronic input, to adjust a gap distance between the second and third planar surfaces. An example of the actuator is any of actuators 330 or 330-1 through 330-3, FIGS. 6A, 7 and 8. A second step 534 operates the electronic input so as to bring a portion of the first electrode into contact with a portion of the second electrode. An example of step 534 is operating actuator 330, FIG. 6A, to bring electrodes 326-5 and 326-6, FIGS. 6A, 6B, into contact with one another. Optionally, the contact between the first and second electrode occurs between a protrusion of one of the electrodes, and a surface of the other electrode; an example of such protrusion is region 360, FIG. 6B. Also optionally, when the portions of the first and second electrodes are in contact with one another, the gap distance away from the point of contact is less than a gap distance sufficient to allow passage or ionized species through the first apertures, the gap and the second apertures, for example 0.005 inches or less. A third step 536 establishes the electronic input to the actuator that corresponds to contact between the portions of the first and second electrodes, as a zero value of the electronic input. An example of step 536 is providing electronic input to a stepper motor acting as height actuator 330 until surface 302 is in contact with region 360, releasing the electronic input with the electrodes in contact, and reestablishing the electronic input at the position of contact. Another example of step 536 is bringing the electrodes into contact using the electronic input, and storing a value of the electronic input at the point of contact as the zero value. A further step 538 operates the electronic input, relative to the zero value, so as to maintain the gap distance at a desired value, according to the known distance response, to modify the fluid communication between the plasma generation chamber and the downstream chamber. An example of step 538 is operating the electronic input to the stepper motor acting as height actuator 330 so as to maintain gap distance G at a desired value, in accordance with a known distance response of the stepper motor.



FIG. 18 is a flowchart of a method 550 for optimizing a plasma apparatus. A first step 552 provides a plasma generation chamber, a downstream chamber, and a two piece electrode assembly between the plasma generation chamber and the downstream chamber. The two piece electrode assembly is operable to modify fluid communication between the plasma generation chamber and the downstream chamber. An example of step 552 is providing plasma generation chamber 215 and downstream chamber 333, with two piece electrode assembly 325 between the two, as shown in FIG. 14. The first electrode defines a plurality of first apertures therethrough. A first surface of the first electrode faces the plasma generation chamber, and a second planar surface of the first electrode faces away from the plasma generation chamber. A second electrode defines a plurality of second apertures therethrough. A third planar surface of the second electrode faces the second planar surface of the first electrode, and a fourth surface of the second electrode faces the downstream chamber. The second and third surfaces are separated by a gap distance. Examples of the first and second electrodes include electrodes 326-1 and 326-2, FIG. 4; 326-3 and 326-4, FIG. 5; 326-5 and 326-6, FIGS. 6A, 6B and 7; and 326-7 and 326-8, FIG. 14. One or more actuators couple the first and second electrodes. The actuators are operable to adjust a position of the first electrode relative to a position of the second electrode. Examples of the actuators are any of actuators 330 or 330-1 through 330-8, FIGS. 6A, 7 and 8. Each of the actuators is characterized by a range of adjustment. For at least one position within the ranges of adjustment of the one or more actuators, the first and second apertures are arranged within the first and second electrodes such that none of the first apertures aligns with any of the second apertures to form an open straight-line path extending through both the first and second electrodes, and the gap distance is between 0.0005 inch and 0.050 inch.


A second step 554 of method 550 operates the one or more actuators so as to dispose the first electrode at a first position relative to the second electrode. An example of step 554 is operating any of actuators 330 or 330-1 through 330-8, FIGS. 6A, 7 and 8 to establish relative positions of electrodes 326-1 and 326-2, FIG. 4; 326-3 and 326-4, FIG. 5; 326-5 and 326-6, FIGS. 6A, 6B and 7; and 326-7 and 326-8, FIG. 14. Step 554 is optional in the sense that the one or more actuators may or may not be operated as method 550 begins, that is, the first and second electrodes may already be in the desired first position. Optionally, also, a workpiece may be transferred into the downstream chamber, either before or after step 554, but this is not required.


A third step 556 of method 510 operates the plasma generation chamber so as to flow at least a first portion of plasma products generated thereby, through the two piece electrode assembly and into the downstream chamber. An example of step 556 is operating plasma system 450, FIG. 14, to generate a plasma 230 within plasma generation chamber 215, and flowing at least a first portion of plasma products generated thereby into downstream chamber 333. As discussed above, certain plasma products may not flow into the downstream chamber, due to the gap distance between the electrodes being sufficiently small, and/or the apertures being out of alignment, so as to keep free electrons and ions generated in the plasma from flowing through the two piece electrode assembly. Also, in step 556, a workpiece may or may not be processed. For example, step 556 may be a chamber cleaning or conditioning operation. A fourth step 558 operates the one or more actuators so as to dispose the first electrode at a second position relative to the second electrode. An example of step 558 is operating any of actuators 330 or 330-1 through 330-8, FIGS. 6A, 7 and 8 to establish relative positions of electrodes 326-1 and 326-2, FIG. 4; 326-3 and 326-4, FIG. 5; 326-5 and 326-6, FIGS. 6A, 6B and 7; and 326-7 and 326-8, FIG. 14 to move one or both of the first electrode and the second electrode. Step 558 may, for example, increase or decrease gap distance G, and may do so across an entire working area of the two piece electrode assembly, or may impart a tilt or gradient to the gap distance at various locations of the assembly. Alternatively or in addition to modifying the gap distance, step 558 may translate and/or rotate one or both of the first and second electrodes, to modify proximity or alignment of apertures therein. Step 558 may occur concurrently with step 552, that is, plasma generation may cease while the actuator(s) move the electrode(s), or plasma generation may continue. Also, optionally, a workpiece may be transferred into the downstream chamber, either before or after step 558, but this is not required.


A further step 560 operates the plasma generation chamber so as to flow at least a second portion of plasma products generated thereby, through the two piece electrode assembly and into the downstream chamber. An example of step 560 is operating plasma system 450, FIG. 14, to generate a plasma 230 within plasma generation chamber 215, and flowing at least a first portion of plasma products generated thereby into downstream chamber 333. Again, as discussed above, certain plasma products may not flow into the downstream chamber, due to the gap distance between the electrodes being sufficiently small, and/or the apertures being out of alignment, so as to keep free electrons and ions generated in the plasma from flowing through the two piece electrode assembly. Again also, in step 560, a workpiece may or may not be processed. For example, step 560 may be a chamber cleaning or conditioning operation.


Because it includes the ability to reposition one or both electrodes of a two piece electrode assembly, and such repositioning can be used to modify fluid communication between a plasma generation chamber and a downstream chamber, method 550 enables processing within a downstream chamber in ways that are believed previously unavailable in plasma systems. For example, changes in gap distance and/or aperture alignment between the two electrodes can enable a designer or engineer of a plasma process to selectively allow or restrict flow of plasma, free electrons and/or ionic species through the electrode assembly without physically changing out one electrode (e.g., a faceplate, showerhead, ion suppressor, plasma blocking screen or the like) for another.


Embodiments herein may be rearranged and may form a variety of shapes. For example, many components shown in FIGS. 2-5, 6A, 7, 8 and 14, such as gas inlet assembly 205, plasma generation chamber 215, faceplate 217, an ion suppressor 223, a showerhead 225, and a workpiece support or pedestal 265, and others may be substantially radially symmetric about a central axis, for processing a circular semiconductor wafer as workpiece 255. However, such features may be of any shape that is consistent with use as a plasma source for other workpieces. Exact numbers and placement of features for introducing and distributing gases and/or plasma products, such as diffusers, face plates and the like, may also vary. Moreover, multiple locations may be used to generate plasmas, and other components of plasma processing systems herein may be configured to add or mix gases with other gases and/or plasma products as they pass through such systems toward a downstream chamber or process chamber. As also suggested by FIGS. 2-5, 6A, 7, 8 and 14, many system components will form perforate planar shapes within central regions of a plasma processing unit so as to provide uniform process conditions across a working area 291 that is about the size of a planar workpiece 255, but the system components may also form different shapes such as flanges, thickness changes, solid imperforate surfaces, and the like at edges of the plasma processing system for structural purposes. Extent of the working area may vary, in embodiments, to accommodate different workpiece sizes, especially but not limited to, diameters of wafers as workpieces 255. When workpiece 255 is a wafer, the working area 291 will generally, but need not always, encompass a central region that extends at least to one-half of a radius of each such system component.


Specific details are given in the above description to provide a thorough understanding of the embodiments. However, it is understood that the embodiments may be practiced without these specific details. For example, well-known processes, structures, and techniques may be shown without unnecessary detail in order to avoid obscuring the embodiments. While the principles of the disclosure have been described above in connection with specific apparatuses and methods, it is to be clearly understood that this description is made only by way of example and not as limitation on the scope of the disclosure.


It is appreciated that the arrangements shown are exemplary only; other embodiments may differ greatly in configuration, including how source gases are introduced, how electrodes and insulators are arranged, how plasma and/or plasma products are handled after generation, and how grooves are formed in insulators. It is contemplated that the techniques and apparatus disclosed herein are applicable to these and other arrangements wherein conductive material builds up during use and thereby creates leakage and/or discharge paths.


As used herein and in the appended claims, the singular forms “a”, “an”, and “the” include plural referents unless the context clearly dictates otherwise. Thus, for example, reference to “a process” includes a plurality of such processes and reference to “the electrode” includes reference to one or more electrodes and equivalents thereof known to those skilled in the art, and so forth. Also, the words “comprise,” “comprising,” “include,” “including,” and “includes” when used in this specification and in the following claims are intended to specify the presence of stated features, integers, components, or steps, but they do not preclude the presence or addition of one or more other features, integers, components, steps, acts, or groups.

Claims
  • 1. An apparatus for distributing plasma products, comprising: a first electrode, comprising a first planar surface and a second planar surface separated by a first electrode thickness that is between 0.125 inch and 1.000 inch, wherein the first electrode forms a plurality of first apertures extending therethrough, from the first planar surface to the second planar surface; anda second electrode, comprising a third planar surface and a fourth planar surface separated by a second electrode thickness that is between 0.125 inch and 1.000 inch, wherein the second electrode forms a plurality of second apertures extending therethrough, from the third planar surface to the fourth planar surface;wherein:the second electrode couples with the first electrode through one or more adjustable couplers such that the third planar surface is disposed adjacent to the second planar surface with a gap therebetween, the gap being characterized by a gap distance;each of the one or more adjustable couplers has a range of adjustment; andfor at least a first position within the range of adjustment of each of the one or more adjustable couplers: the first and second apertures are arranged within the first and second electrodes, such that none of the first apertures aligns with any of the second apertures to form an open straight-line path extending through both the first and second electrodes; andthe gap distance is between 0.005 inch and 0.050 inch.
  • 2. The apparatus of claim 1, wherein the one or more adjustable couplers are adjustable using a hand tool, but are not operably coupled with actuators.
  • 3. The apparatus of claim 1, wherein the one or more adjustable couplers are actuators that activate in response to electronic input.
  • 4. The apparatus of claim 1, wherein the first and second electrodes and the one or more adjustable couplers are connected with one or more RF grounding straps, so that the first and second electrodes and the one or more adjustable couplers are held at a common electrical potential.
  • 5. The apparatus of claim 1, wherein at least one of the one or more adjustable couplers is operable to adjust one or more of translation and rotation of the second planar surface with respect to the third planar surface, without substantially changing the gap distance, so that at a second position within the range of adjustment of the at least one of the one or more adjustable couplers, one or more of the first apertures is brought at least within a lateral distance of one or more of the second apertures, the lateral distance being less than three times the gap distance.
  • 6. The apparatus of claim 5, wherein at the second position, one or more of the first apertures aligns with one or more of the second apertures so as to form an open straight-line path extending through both the first and second electrodes.
  • 7. The apparatus of claim 1, wherein a first one of the one or more adjustable couplers is operable to adjust the gap distance.
  • 8. The apparatus of claim 7, wherein the first one of the one or more adjustable couplers is a single adjustable coupler that is operable to adjust the gap distance but does not substantially change parallelism of the second and third planar surfaces with respect to one another.
  • 9. The apparatus of claim 8, further comprising: a housing; anda suspension mechanism;and wherein:one of the first and second electrodes is fixedly coupled with the housing, and the other of the first and second electrodes is coupled with the suspension mechanism;the suspension mechanism transfers at least a portion of a weight of the other of the first and second electrodes to the housing; andthe first one of the one or more adjustable couplers cooperates with the suspension mechanism to adjust the gap distance, while not substantially changing parallelism of the second and third planar surfaces with respect to one another.
  • 10. The apparatus of claim 9, wherein: the first one of the one or more adjustable couplers comprises a stepper motor; andthe suspension mechanism comprises a bracket coupled with one or more springs.
  • 11. The apparatus of claim 7, wherein a second one of the one or more adjustable couplers is operable to adjust parallelism of the second and third planar surfaces with respect to one another.
  • 12. The apparatus of claim 11, wherein: the first one of the one or more adjustable couplers adjusts the gap distance at a first attachment point about a periphery of the second electrode, andsecond and third adjustable couplers of the one or more adjustable couplers adjust the gap distance at second and third attachment points about the periphery of the second electrode so that the first, second and third adjustable couplers can apply a tilt to the second electrode, relative to the first electrode, at any azimuthal angle.
  • 13. A plasma processing apparatus, comprising: a plasma generator;a processing chamber operable to receive and position a workpiece for processing; andthe apparatus of claim 1, disposed between and sealed with the plasma generator and the processing chamber, such that plasma products generated by the plasma generator must pass through the first apertures, the gap, and the second apertures, to enter the processing chamber.
  • 14. An apparatus for distributing plasma products, comprising: a first electrode, comprising a first planar surface and a second planar surface separated by a first electrode thickness that is between 0.100 inch and 1.000 inch, wherein the first electrode forms a plurality of first apertures extending therethrough, from the first planar surface to the second planar surface; anda second electrode, comprising a third planar surface and a fourth planar surface separated by a second electrode thickness that is between 0.100 inch and 1.000 inch, wherein the second electrode forms a plurality of second apertures extending therethrough, from the third planar surface to the fourth planar surface;wherein:the second electrode is coupled fixedly with the first electrode such that the third planar surface is disposed adjacent to the second planar surface, with a gap distance of 0.005 inches to 0.050 inches therebetween; andthe first and second apertures are arranged within the first and second electrodes such that none of the first apertures aligns with any of the second apertures to form an open straight-line path extending through both the first and second electrodes.
  • 15. The apparatus of claim 14, wherein a lateral distance from any point within one of the first apertures, to any point within any of the second apertures, is greater than three times the gap distance.
  • 16. The apparatus of claim 14, wherein each of the first and second apertures is cylindrical and is of the same diameter, and the diameter is between 0.036 and 0.350 inches.
  • 17. The apparatus of claim 14, wherein at least 100 of the first apertures are arranged in a rectilinear grid across the first electrode and at least 100 of the second apertures are arranged in a rectilinear grid across the second electrode.
  • 18. The apparatus of claim 14, wherein the first and second electrodes are connected with one or more RF grounding straps, so that the first and second electrodes are held at a common electrical potential.
  • 19. A plasma source, comprising: a plasma generation region configured for introduction of one or more source gases therein;an RF power supply that provides electromagnetic power to the one or more source gases to ignite a plasma within the plasma generation region;a two piece electrode assembly that bounds the plasma generation region on one side, the two piece electrode assembly comprising:a first electrode that defines a first planar surface and a second planar surface, wherein: the first planar surface and the second planar surface are separated by a first electrode thickness that is between 0.100 inch and 1.000 inch, andthe first electrode forms a plurality of first apertures extending therethrough, from the first planar surface to the second planar surface; anda second electrode that defines a third planar surface and a fourth planar surface, wherein: the third planar surface and the fourth planar surface separated by a second electrode thickness that is between 0.100 inch and 1.000 inch,the second electrode forms a plurality of second apertures extending therethrough, from the third planar surface to the fourth planar surface,the second electrode is coupled with the first electrode on the one side of the plasma generation region, such that the third planar surface is disposed adjacent to the second planar surface; andthe first electrode and the second electrode are fixed or positionable with respect to one another so as to provide: a gap between the first electrode and the second electrode, the gap forming a gap distance of 0.005 inches to 0.050 inches between the second planar surface and the third planar surface, anda lateral separation of any point within one of the first apertures, with respect to any point within any of the second apertures, of greater than three times the gap distance; andthe plasma source further comprising a second region that is bounded on at least one side by the fourth planar surface of the second electrode, wherein the gap and the lateral separation cooperate to substantially reduce transmission of free electrons and ionized species from the plasma generation region to the second region.
  • 20. The plasma source of claim 19, wherein the first and second electrodes are positionable with respect to one another through one or more adjustable couplers that are operable to adjust at least one of: the gap distance; andlateral alignment of the first and second apertures relative to one another.
US Referenced Citations (2097)
Number Name Date Kind
2369620 Sullivan et al. Feb 1945 A
3401302 Thorpe Sep 1968 A
3451840 Hough Jun 1969 A
3537474 Rohrer Nov 1970 A
3756511 Shinroku Sep 1973 A
3937857 Brummett et al. Feb 1976 A
3969077 Hill Jul 1976 A
4006047 Brummett et al. Feb 1977 A
4190488 Winters Feb 1980 A
4209357 Gorin et al. Jun 1980 A
4214946 Forget et al. Jul 1980 A
4232060 Mallory, Jr. Nov 1980 A
4234628 DuRose Nov 1980 A
4265943 Goldstein et al. May 1981 A
4340462 Koch Jul 1982 A
4341592 Shortes et al. Jul 1982 A
4361418 Tscheppe Nov 1982 A
4361441 Tylko Nov 1982 A
4364803 Nidola et al. Dec 1982 A
4368223 Kobayashi et al. Jan 1983 A
4374698 Sanders et al. Feb 1983 A
4397812 Mallory, Jr. Aug 1983 A
4468413 Bachmann Aug 1984 A
4503807 Nakayama et al. Mar 1985 A
4565601 Kakehi et al. Jan 1986 A
4579618 Celestino et al. Apr 1986 A
4585920 Hoog et al. Apr 1986 A
4600464 Desliets et al. Jul 1986 A
4610775 Phifer Sep 1986 A
4625678 Shloya et al. Dec 1986 A
4632857 Mallory, Jr. Dec 1986 A
4656052 Satou et al. Apr 1987 A
4656076 Vetanen et al. Apr 1987 A
4668335 Mockler May 1987 A
4690746 McInerney et al. Sep 1987 A
4715937 Moslehi et al. Dec 1987 A
4749440 Blackwood et al. Jun 1988 A
4753898 Parrillo et al. Jun 1988 A
4786360 Cote et al. Nov 1988 A
4792378 Rose et al. Dec 1988 A
4793897 Dunfield et al. Dec 1988 A
4807016 Douglas Feb 1989 A
4810520 Wu Mar 1989 A
4816638 Ukai et al. Mar 1989 A
4820377 Davis et al. Apr 1989 A
4828649 Davis May 1989 A
4857140 Loewenstein Aug 1989 A
4867841 Loewenstein et al. Sep 1989 A
4904621 Lowenstein et al. Feb 1990 A
4913929 Moslehi et al. Apr 1990 A
4919750 Bausmith et al. Apr 1990 A
4946903 Gardella et al. Aug 1990 A
4951601 Maydan et al. Aug 1990 A
4960488 Law et al. Oct 1990 A
4980018 Mu et al. Dec 1990 A
4981551 Palmour Jan 1991 A
4985372 Narita et al. Jan 1991 A
4987856 Hey et al. Jan 1991 A
4991542 Kohmura et al. Feb 1991 A
4992136 Tachi et al. Feb 1991 A
4993358 Mahawili Feb 1991 A
4994404 Sheng et al. Feb 1991 A
5000113 Wang et al. Mar 1991 A
5006192 Deguchi Apr 1991 A
5010842 Oda et al. Apr 1991 A
5013691 Lory et al. May 1991 A
5028565 Chang Jul 1991 A
5030319 Nishino et al. Jul 1991 A
5038713 Kawakami et al. Aug 1991 A
5045244 Marlett Sep 1991 A
5061838 Lane et al. Oct 1991 A
5069938 Lorimer et al. Dec 1991 A
5074456 Degner et al. Dec 1991 A
5083030 Stavov Jan 1992 A
5089441 Moslehi Feb 1992 A
5089442 Olmer Feb 1992 A
5147692 Bengston Sep 1992 A
5156881 Okano et al. Oct 1992 A
5180435 Markunas et al. Jan 1993 A
5186718 Tepman et al. Feb 1993 A
5188706 Hori et al. Feb 1993 A
5198034 deBoer et al. Mar 1993 A
5200016 Namose Apr 1993 A
5203911 Sricharoenchalkit et al. Apr 1993 A
5215787 Homma Jun 1993 A
5217559 Moslehi et al. Jun 1993 A
5221427 Koinuma et al. Jun 1993 A
5228501 Tepman et al. Jul 1993 A
5231690 Soma et al. Jul 1993 A
5235139 Bengston et al. Aug 1993 A
5238499 van de Ven et al. Aug 1993 A
5240497 Shacham et al. Aug 1993 A
5248371 Maher et al. Sep 1993 A
5248527 Uchida et al. Sep 1993 A
5252178 Moslehi Oct 1993 A
5266157 Kadomura Nov 1993 A
5269881 Sekiya Dec 1993 A
5270125 America et al. Dec 1993 A
5271972 Kwok et al. Dec 1993 A
5275977 Otsubo et al. Jan 1994 A
5277750 Wolgang Jan 1994 A
5279669 Lee Jan 1994 A
5279865 Chebi et al. Jan 1994 A
5288518 Homma Feb 1994 A
5290382 Zarowin et al. Mar 1994 A
5290383 Koshimizu Mar 1994 A
5292370 Tsai et al. Mar 1994 A
5292682 Stevens et al. Mar 1994 A
5300463 Cathey et al. Apr 1994 A
5302233 Kim et al. Apr 1994 A
5304250 Sameshima et al. Apr 1994 A
5306530 Strongin et al. Apr 1994 A
5314724 Tsukune et al. May 1994 A
5319247 Matsuura Jun 1994 A
5326427 Jerbic Jul 1994 A
5328558 Kawamura et al. Jul 1994 A
5328810 Lowrey et al. Jul 1994 A
5330578 Sakama Jul 1994 A
5334552 Homma Aug 1994 A
5345999 Hosokawa Sep 1994 A
5352636 Beinglass Oct 1994 A
5356478 Chen et al. Oct 1994 A
5362526 Wang et al. Nov 1994 A
5366585 Robertson et al. Nov 1994 A
5368897 Kurihara et al. Nov 1994 A
5378316 Franke et al. Jan 1995 A
5380560 Kaja et al. Jan 1995 A
5382311 Ishikawa et al. Jan 1995 A
5384284 Doan et al. Jan 1995 A
5385763 Okano et al. Jan 1995 A
5399237 Keswick et al. Mar 1995 A
5399529 Homma Mar 1995 A
5403434 Moslehi Apr 1995 A
5413670 Langan et al. May 1995 A
5413967 Matsuda et al. May 1995 A
5415890 Kloiber et al. May 1995 A
5416048 Blalock et al. May 1995 A
5420075 Homma et al. May 1995 A
5429995 Nishiyama et al. Jul 1995 A
5439553 Grant et al. Aug 1995 A
5451169 Corbett, III et al. Sep 1995 A
5451259 Krogh Sep 1995 A
5454170 Cook Oct 1995 A
5464499 Moslehi Nov 1995 A
5468342 Nulty et al. Nov 1995 A
5474589 Ohga et al. Dec 1995 A
5478403 Shinigawa et al. Dec 1995 A
5478462 Walsh Dec 1995 A
5483920 Pryor Jan 1996 A
5494494 Mizuno et al. Feb 1996 A
5500249 Telford et al. Mar 1996 A
5505816 Barnes et al. Apr 1996 A
5510216 Calabrese et al. Apr 1996 A
5516367 Lei et al. May 1996 A
5518962 Murao May 1996 A
5531835 Fodor et al. Jul 1996 A
5534070 Okamura et al. Jul 1996 A
5536360 Nguyen et al. Jul 1996 A
5549780 Koinuma et al. Aug 1996 A
5556521 Ghanbari Sep 1996 A
5558717 Zhao et al. Sep 1996 A
5560779 Knowles et al. Oct 1996 A
5563105 Dobuzinsky et al. Oct 1996 A
5567243 Foster et al. Oct 1996 A
5571576 Qian et al. Nov 1996 A
5575853 Arami et al. Nov 1996 A
5578130 Hayashi et al. Nov 1996 A
5578161 Auda Nov 1996 A
5580385 Paranjpe et al. Dec 1996 A
5580421 Hiatt et al. Dec 1996 A
5591269 Arami et al. Jan 1997 A
5592358 Shamouilian Jan 1997 A
5595606 Fujikawa et al. Jan 1997 A
5597439 Salzman Jan 1997 A
5599740 Jang et al. Feb 1997 A
5614055 Fairbairn et al. Mar 1997 A
5616518 Foo et al. Apr 1997 A
5624582 Cain Apr 1997 A
5626922 Miyanaga et al. May 1997 A
5628829 Foster et al. May 1997 A
5635086 Warren, Jr. Jun 1997 A
5645645 Zhang et al. Jul 1997 A
5648125 Cane Jul 1997 A
5648175 Russell et al. Jul 1997 A
5656093 Burkhart et al. Aug 1997 A
5660957 Chou et al. Aug 1997 A
5661093 Ravi et al. Aug 1997 A
5670066 Barnes et al. Sep 1997 A
5674787 Zhao et al. Oct 1997 A
5676758 Hasgawa et al. Oct 1997 A
5679606 Wang et al. Oct 1997 A
5685946 Fathauer et al. Nov 1997 A
5688331 Aruga et al. Nov 1997 A
5695810 Dubin et al. Dec 1997 A
5712185 Tsai et al. Jan 1998 A
5716500 Bardos et al. Feb 1998 A
5716506 Maclay et al. Feb 1998 A
5719085 Moon et al. Feb 1998 A
5733816 Iyer et al. Mar 1998 A
5747373 Yu May 1998 A
5753886 Iwamura et al. May 1998 A
5755859 Brusic et al. May 1998 A
5756400 Ye et al. May 1998 A
5756402 Jimbo et al. May 1998 A
5772770 Suda et al. Jun 1998 A
5781693 Ballance et al. Jul 1998 A
5786276 Brooks et al. Jul 1998 A
5788825 Park et al. Aug 1998 A
5789300 Fulford Aug 1998 A
5792376 Kanai et al. Aug 1998 A
5800686 Littau et al. Sep 1998 A
5804259 Robles Sep 1998 A
5812403 Fong et al. Sep 1998 A
5814238 Ashby et al. Sep 1998 A
5814365 Mahawill Sep 1998 A
5820723 Benjamin et al. Oct 1998 A
5824599 Schacham-Diamand et al. Oct 1998 A
5830805 Schacham-Diamand et al. Nov 1998 A
5835334 McMillin et al. Nov 1998 A
5843538 Ehrsam et al. Dec 1998 A
5843847 Pu et al. Dec 1998 A
5844195 Fairbairn et al. Dec 1998 A
5846332 Zhao et al. Dec 1998 A
5846373 Pirkle et al. Dec 1998 A
5846375 Gilchrist et al. Dec 1998 A
5846598 Semkow et al. Dec 1998 A
5849639 Molloy et al. Dec 1998 A
5850105 Dawson et al. Dec 1998 A
5855681 Maydan et al. Jan 1999 A
5855685 Tobe et al. Jan 1999 A
5856240 Sinha et al. Jan 1999 A
5858876 Chew Jan 1999 A
5863376 Wicker Jan 1999 A
5865896 Nowak Feb 1999 A
5866483 Shiau et al. Feb 1999 A
5868897 Ohkawa Feb 1999 A
5872052 Iyer Feb 1999 A
5872058 Van Cleemput et al. Feb 1999 A
5882424 Taylor et al. Mar 1999 A
5882786 Nassau et al. Mar 1999 A
5883012 Chiou Mar 1999 A
5885404 Kim et al. Mar 1999 A
5885749 Huggins et al. Mar 1999 A
5888906 Sandhu et al. Mar 1999 A
5891349 Tobe et al. Apr 1999 A
5891513 Dubin et al. Apr 1999 A
5897751 Makowiecki Apr 1999 A
5899752 Hey et al. May 1999 A
5900163 Yi et al. May 1999 A
5904827 Reynolds May 1999 A
5907790 Kellam May 1999 A
5910340 Uchida et al. Jun 1999 A
5913147 Dubin et al. Jun 1999 A
5913978 Kato et al. Jun 1999 A
5915190 Pirkle Jun 1999 A
5918116 Chittipeddi Jun 1999 A
5919332 Koshiishi et al. Jul 1999 A
5920792 Lin Jul 1999 A
5926737 Ameen et al. Jul 1999 A
5928528 Kubota et al. Jul 1999 A
5932077 Reynolds Aug 1999 A
5933757 Yoshikawa et al. Aug 1999 A
5935334 Fong et al. Aug 1999 A
5935340 Xia et al. Aug 1999 A
5937323 Orczyk et al. Aug 1999 A
5939831 Fong et al. Aug 1999 A
5942075 Nagahata et al. Aug 1999 A
5944049 Beyer et al. Aug 1999 A
5944902 Redeker et al. Aug 1999 A
5948702 Rotondaro Sep 1999 A
5951601 Lesinski et al. Sep 1999 A
5951776 Selyutin et al. Sep 1999 A
5951896 Mahawill Sep 1999 A
5953591 Ishihara et al. Sep 1999 A
5953635 Andideh Sep 1999 A
5963840 Xia et al. Oct 1999 A
5968379 Zhao et al. Oct 1999 A
5968587 Frankel et al. Oct 1999 A
5968610 Liu et al. Oct 1999 A
5969422 Ting et al. Oct 1999 A
5976327 Tanaka Nov 1999 A
5982100 Ghanbari Nov 1999 A
5990000 Hong et al. Nov 1999 A
5990013 Berenguer et al. Nov 1999 A
5993916 Zhao et al. Nov 1999 A
5994209 Yieh et al. Nov 1999 A
5997649 Hillman Dec 1999 A
5997721 Limbach et al. Dec 1999 A
5997962 Ogasawara et al. Dec 1999 A
6004884 Abraham Dec 1999 A
6007635 Mahawill Dec 1999 A
6007785 Liou Dec 1999 A
6010962 Liu et al. Jan 2000 A
6013191 Nasser-Faili et al. Jan 2000 A
6013584 M'Saad Jan 2000 A
6015724 Yamazaki et al. Jan 2000 A
6015747 Lopatin et al. Jan 2000 A
6017414 Koemtzopoulos et al. Jan 2000 A
6019848 Kiyama et al. Feb 2000 A
6020271 Yanagida Feb 2000 A
6030666 Lam et al. Feb 2000 A
6030881 Papasouliotis et al. Feb 2000 A
6035101 Sajoto et al. Mar 2000 A
6036878 Collins et al. Mar 2000 A
6037018 Jang et al. Mar 2000 A
6037266 Tao et al. Mar 2000 A
6039834 Tanaka et al. Mar 2000 A
6039851 Iyer Mar 2000 A
6053982 Halpin et al. Apr 2000 A
6059643 Hu et al. May 2000 A
6063683 Wu et al. May 2000 A
6063712 Gilton et al. May 2000 A
6065424 Shacham-Diamand et al. May 2000 A
6065425 Takaki et al. May 2000 A
6072147 Koshiishi Jun 2000 A
6072227 Yau et al. Jun 2000 A
6074512 Collins et al. Jun 2000 A
6074514 Bjorkman et al. Jun 2000 A
6077384 Collins et al. Jun 2000 A
6077386 Smith, Jr. et al. Jun 2000 A
6077780 Dubin Jun 2000 A
6079356 Umotoy et al. Jun 2000 A
6080529 Ye et al. Jun 2000 A
6081414 Flanigan et al. Jun 2000 A
6083344 Hanawa et al. Jul 2000 A
6083844 Bui-Le et al. Jul 2000 A
6086677 Umotoy et al. Jul 2000 A
6087278 Kim et al. Jul 2000 A
6090212 Mahawill Jul 2000 A
6093457 Okumura Jul 2000 A
6093594 Yeap et al. Jul 2000 A
6099697 Hausmann Aug 2000 A
6107199 Allen et al. Aug 2000 A
6110530 Chen et al. Aug 2000 A
6110832 Morgan et al. Aug 2000 A
6110836 Cohen et al. Aug 2000 A
6110838 Loewenstein Aug 2000 A
6113771 Landau et al. Sep 2000 A
6114216 Yieh et al. Sep 2000 A
6117245 Mandrekar et al. Sep 2000 A
6120640 Shih et al. Sep 2000 A
6124003 Mikami et al. Sep 2000 A
6126753 Shinriki et al. Oct 2000 A
6132512 Horie et al. Oct 2000 A
6136163 Cheung et al. Oct 2000 A
6136165 Moslehi et al. Oct 2000 A
6136685 Narwankar et al. Oct 2000 A
6136693 Chan et al. Oct 2000 A
6140234 Uzoh et al. Oct 2000 A
6144099 Lopatin et al. Nov 2000 A
6147009 Grill et al. Nov 2000 A
6148761 Majewski et al. Nov 2000 A
6149828 Vaartstra Nov 2000 A
6150628 Smith et al. Nov 2000 A
6153935 Edelstein et al. Nov 2000 A
6161500 Kopacz et al. Dec 2000 A
6161576 Maher et al. Dec 2000 A
6162302 Raghavan et al. Dec 2000 A
6162370 Hackett et al. Dec 2000 A
6165912 McConnell et al. Dec 2000 A
6167834 Wang et al. Jan 2001 B1
6169021 Akram et al. Jan 2001 B1
6170428 Redeker et al. Jan 2001 B1
6170429 Schoepp Jan 2001 B1
6171661 Zheng et al. Jan 2001 B1
6174450 Patrick et al. Jan 2001 B1
6174810 Patrick et al. Jan 2001 B1
6174812 Hsuing et al. Jan 2001 B1
6176198 Kao et al. Jan 2001 B1
6176667 Fairbairn Jan 2001 B1
6177245 Ward et al. Jan 2001 B1
6179924 Zhao et al. Jan 2001 B1
6180523 Lee et al. Jan 2001 B1
6182602 Redeker et al. Feb 2001 B1
6182603 Shang et al. Feb 2001 B1
6184121 Buchwalter et al. Feb 2001 B1
6184489 Ito et al. Feb 2001 B1
6186091 Chu et al. Feb 2001 B1
6189483 Ishikawa et al. Feb 2001 B1
6190233 Hong et al. Feb 2001 B1
6194038 Rossman Feb 2001 B1
6197181 Chen Mar 2001 B1
6197364 Paunovic et al. Mar 2001 B1
6197680 Lin et al. Mar 2001 B1
6197688 Simpson Mar 2001 B1
6197705 Vassiliev Mar 2001 B1
6198616 Dahimene et al. Mar 2001 B1
6200412 Kilgore et al. Mar 2001 B1
6203863 Liu et al. Mar 2001 B1
6204200 Shieh et al. Mar 2001 B1
6210486 Mizukami et al. Apr 2001 B1
6217658 Orczyk et al. Apr 2001 B1
6220201 Nowak Apr 2001 B1
6225745 Srivastava May 2001 B1
6228233 Lakshmikanthan et al. May 2001 B1
6228751 Yamazaki et al. May 2001 B1
6228758 Pellerin et al. May 2001 B1
6235643 Mui et al. May 2001 B1
6237527 Kellerman et al. May 2001 B1
6238513 Arnold et al. May 2001 B1
6238582 Williams et al. May 2001 B1
6197151 Kaji et al. Jun 2001 B1
6241845 Gadgil et al. Jun 2001 B1
6242349 Nogami et al. Jun 2001 B1
6242360 Fischer et al. Jun 2001 B1
6244211 Nishikawa et al. Jun 2001 B1
6245396 Nogami Jun 2001 B1
6245670 Cheung et al. Jun 2001 B1
6251236 Stevens Jun 2001 B1
6251802 Moore et al. Jun 2001 B1
6258170 Somekh et al. Jul 2001 B1
6258220 Dordi et al. Jul 2001 B1
6258223 Cheung et al. Jul 2001 B1
6258270 Hilgendorff et al. Jul 2001 B1
6261637 Oberle Jul 2001 B1
6267074 Okumura Jul 2001 B1
6277733 Smith Aug 2001 B1
6277752 Chen Aug 2001 B1
6277763 Kugimiya et al. Aug 2001 B1
6281072 Li et al. Aug 2001 B1
6281135 Han et al. Aug 2001 B1
6284146 Kim et al. Sep 2001 B1
6291282 Wilk et al. Sep 2001 B1
6291348 Lopatin et al. Sep 2001 B1
6302964 Umotoy et al. Oct 2001 B1
6303044 Koemtzopoulos Oct 2001 B1
6303418 Cha et al. Oct 2001 B1
6306246 Melvin et al. Oct 2001 B1
6306772 Lin Oct 2001 B1
6308654 Schneider et al. Oct 2001 B1
6308776 Sloan Oct 2001 B1
6310755 Busato et al. Oct 2001 B1
6312554 Ye Nov 2001 B1
6312995 Yu Nov 2001 B1
6319387 Krishnamoorthy et al. Nov 2001 B1
6321587 Laush Nov 2001 B1
6322716 Qiao et al. Nov 2001 B1
6323128 Sambucetti et al. Nov 2001 B1
6335288 Kwan et al. Jan 2002 B1
6340435 Bjorkman et al. Jan 2002 B1
6342733 Hu et al. Jan 2002 B1
RE37546 Mahawill Feb 2002 E
6344410 Lopatin et al. Feb 2002 B1
6348407 Gupta et al. Feb 2002 B1
6350320 Sherstinsky et al. Feb 2002 B1
6350697 Richardson Feb 2002 B1
6351013 Luning et al. Feb 2002 B1
6352081 Lu et al. Mar 2002 B1
6355573 Okumura Mar 2002 B1
6358827 Chen et al. Mar 2002 B1
6364949 Or et al. Apr 2002 B1
6364954 Umotoy et al. Apr 2002 B2
6364957 Schneider et al. Apr 2002 B1
6375748 Yudovsky et al. Apr 2002 B1
6376386 Oshima Apr 2002 B1
6379575 Yin et al. Apr 2002 B1
6383896 Kirimura et al. May 2002 B1
6383951 Li May 2002 B1
6387207 Janakiraman et al. May 2002 B1
6391753 Yu May 2002 B1
6395150 Van Cleemput et al. May 2002 B1
6403491 Liu et al. Jun 2002 B1
6415736 Hao et al. Jul 2002 B1
6416647 Dordi et al. Jul 2002 B1
6418874 Cox et al. Jul 2002 B1
6423284 Arno Jul 2002 B1
6427623 Ko Aug 2002 B2
6429465 Yagi et al. Aug 2002 B1
6432819 Pavate et al. Aug 2002 B1
6432831 Dhindsa et al. Aug 2002 B2
6436193 Kasai et al. Aug 2002 B1
6436816 Lee et al. Aug 2002 B1
6437512 Chen et al. Aug 2002 B1
6440863 Tsai et al. Aug 2002 B1
6441492 Cunningham Aug 2002 B1
6444083 Steger et al. Sep 2002 B1
6446572 Brcka Sep 2002 B1
6447636 Qian et al. Sep 2002 B1
6448537 Nering Sep 2002 B1
6458718 Todd Oct 2002 B1
6461974 Ni et al. Oct 2002 B1
6462371 Weimer et al. Oct 2002 B1
6462372 Xia et al. Oct 2002 B1
6465051 Sahin et al. Oct 2002 B1
6465350 Taylor et al. Oct 2002 B1
6465366 Nemani et al. Oct 2002 B1
6477980 White et al. Nov 2002 B1
6479373 Dreybrodt et al. Nov 2002 B2
6488984 Wada et al. Dec 2002 B1
6494959 Samoilov et al. Dec 2002 B1
6499425 Sandhu et al. Dec 2002 B1
6500728 Wang Dec 2002 B1
6503843 Xia et al. Jan 2003 B1
6506291 Tsai et al. Jan 2003 B2
6509283 Thomas Jan 2003 B1
6509623 Zhao Jan 2003 B2
6516815 Stevens et al. Feb 2003 B1
6518548 Sugaya et al. Feb 2003 B2
6527968 Wang et al. Mar 2003 B1
6528409 Lopatin et al. Mar 2003 B1
6528751 Hoffman et al. Mar 2003 B1
6531069 Srivastava et al. Mar 2003 B1
6537707 Lee Mar 2003 B1
6537733 Campana et al. Mar 2003 B2
6541397 Bencher Apr 2003 B1
6541671 Martinez et al. Apr 2003 B1
6544340 Yudovsky Apr 2003 B2
6547977 Yan et al. Apr 2003 B1
6551924 Dalton et al. Apr 2003 B1
6558564 Loewenhardt May 2003 B1
6565661 Nguyen May 2003 B1
6565729 Chen et al. May 2003 B2
6569773 Gellrich et al. May 2003 B1
6572937 Hakovirta et al. Jun 2003 B2
6573030 Fairbairn et al. Jun 2003 B1
6573606 Sambucetti et al. Jun 2003 B2
6585851 Ohmi et al. Jul 2003 B1
6586163 Okabe et al. Jul 2003 B1
6596599 Guo Jul 2003 B1
6596654 Bayman et al. Jul 2003 B1
6602434 Hung et al. Aug 2003 B1
6602806 Xia et al. Aug 2003 B1
6603269 Vo et al. Aug 2003 B1
6605874 Leu et al. Aug 2003 B2
6616967 Test Sep 2003 B1
6627532 Gaillard et al. Sep 2003 B1
6635575 Xia et al. Oct 2003 B1
6635578 Xu et al. Oct 2003 B1
6638810 Bakli et al. Oct 2003 B2
6645301 Sainty et al. Nov 2003 B2
6645550 Cheung et al. Nov 2003 B1
6656831 Lee et al. Dec 2003 B1
6656837 Xu et al. Dec 2003 B2
6656848 Scanlan et al. Dec 2003 B1
6663715 Yuda et al. Dec 2003 B1
6673200 Gu et al. Jan 2004 B1
6677242 Liu et al. Jan 2004 B1
6679981 Pan et al. Jan 2004 B1
6688375 Turner Feb 2004 B1
6692903 Chen et al. Feb 2004 B2
6713356 Skotnicki et al. Mar 2004 B1
6713835 Horak et al. Mar 2004 B1
6717189 Inoue et al. Apr 2004 B2
6720213 Gambino et al. Apr 2004 B1
6736147 Satoh et al. May 2004 B2
6736987 Cho May 2004 B1
6740247 Han et al. May 2004 B1
6740585 Yoon et al. May 2004 B2
6740977 Ahn et al. May 2004 B2
6743473 Parkhe et al. Jun 2004 B1
6743732 Lin et al. Jun 2004 B1
6756235 Liu et al. Jun 2004 B1
6759261 Shimokohbe et al. Jul 2004 B2
6762127 Boiteux et al. Jul 2004 B2
6762435 Towle Jul 2004 B2
6764958 Nemani et al. Jul 2004 B1
6765273 Chau et al. Jul 2004 B1
6767834 Chung et al. Jul 2004 B2
6768079 Kosakai Jul 2004 B2
6770166 Fisher Aug 2004 B1
6772827 Keller et al. Aug 2004 B2
6792889 Nakano et al. Sep 2004 B2
6794290 Papasouliotis et al. Sep 2004 B1
6794311 Huang et al. Sep 2004 B2
6796314 Graff et al. Sep 2004 B1
6797189 Hung et al. Sep 2004 B2
6800336 Fornsel et al. Oct 2004 B1
6800830 Mahawili Oct 2004 B2
6802944 Ahmad et al. Oct 2004 B2
6808564 Dietze Oct 2004 B2
6808747 Shih et al. Oct 2004 B1
6808748 Kapoor et al. Oct 2004 B2
6815633 Chen et al. Nov 2004 B1
6818561 Sonderman Nov 2004 B1
6821571 Huang Nov 2004 B2
6823589 White et al. Nov 2004 B2
6828241 Kholodenko et al. Dec 2004 B2
6830624 Janakiraman et al. Dec 2004 B2
6835995 Li Dec 2004 B2
6846401 Wijenberg et al. Jan 2005 B2
6846745 Papasouliotis et al. Jan 2005 B1
6849854 Sainty Feb 2005 B2
6852550 Tuttle et al. Feb 2005 B2
6852584 Chen et al. Feb 2005 B1
6853533 Parkhe et al. Feb 2005 B2
6858153 Bjorkman et al. Feb 2005 B2
6861097 Goosey et al. Mar 2005 B1
6861332 Park et al. Mar 2005 B2
6869880 Krishnaraj et al. Mar 2005 B2
6875280 Ikeda et al. Apr 2005 B2
6878206 Tzu et al. Apr 2005 B2
6879981 Rothschild et al. Apr 2005 B2
6886491 Kim et al. May 2005 B2
6892669 Xu et al. May 2005 B2
6893967 Wright et al. May 2005 B1
6897532 Schwarz et al. May 2005 B1
6900596 Yang et al. May 2005 B2
6903511 Chistyakov Jun 2005 B2
6908862 Li et al. Jun 2005 B2
6911112 An Jun 2005 B2
6911401 Khandan et al. Jun 2005 B2
6916399 Rozenzon et al. Jul 2005 B1
6921556 Shimizu et al. Jul 2005 B2
6924191 Liu et al. Aug 2005 B2
6930047 Yamazaki Aug 2005 B2
6935269 Lee et al. Aug 2005 B2
6942753 Choi et al. Sep 2005 B2
6946033 Tsuel et al. Sep 2005 B2
6951821 Hamelin et al. Oct 2005 B2
6958175 Sakamoto et al. Oct 2005 B2
6958286 Chen et al. Oct 2005 B2
6969619 Winniczek Nov 2005 B1
6972840 Gu et al. Dec 2005 B1
6995073 Liou Feb 2006 B2
7017269 White et al. Mar 2006 B2
7018941 Cui et al. Mar 2006 B2
7030034 Fucsko et al. Apr 2006 B2
7049200 Arghavani et al. May 2006 B2
7049244 Becker et al. May 2006 B2
7052553 Shih et al. May 2006 B1
7071532 Geffken et al. Jul 2006 B2
7084070 Lee et al. Aug 2006 B1
7115525 Abatchev et al. Oct 2006 B2
7122949 Strikovski Oct 2006 B2
7138767 Chen et al. Nov 2006 B2
7145725 Hasel et al. Dec 2006 B2
7148155 Tarafdar et al. Dec 2006 B1
7166233 Johnson et al. Jan 2007 B2
7183214 Nam et al. Feb 2007 B2
7196342 Ershov et al. Mar 2007 B2
7226805 Hallin et al. Jun 2007 B2
7235137 Kitayama et al. Jun 2007 B2
7244474 Hanawa et al. Jul 2007 B2
7252011 Traverso Aug 2007 B2
7252716 Kim et al. Aug 2007 B2
7253123 Arghavani et al. Aug 2007 B2
7256370 Guiver Aug 2007 B2
7274004 Benjamin et al. Sep 2007 B2
7288482 Panda et al. Oct 2007 B2
7291360 Hanawa et al. Nov 2007 B2
7297894 Tsukamoto Nov 2007 B1
7316761 Doan et al. Jan 2008 B2
7329608 Babayan et al. Feb 2008 B2
7341633 Lubomirsky et al. Mar 2008 B2
7344912 Okoroanyanwu Mar 2008 B1
7358192 Merry et al. Apr 2008 B2
7361865 Maki et al. Apr 2008 B2
7364956 Saito Apr 2008 B2
7365016 Ouellet et al. Apr 2008 B2
7396480 Kao et al. Jul 2008 B2
7396773 Blosse et al. Jul 2008 B1
7416989 Liu et al. Aug 2008 B1
7465358 Weidman et al. Dec 2008 B2
7465953 Koh et al. Dec 2008 B1
7468319 Lee Dec 2008 B2
7479303 Byun et al. Jan 2009 B2
7484473 Keller et al. Feb 2009 B2
7488688 Chung et al. Feb 2009 B2
7494545 Lam et al. Feb 2009 B2
7500445 Zhao et al. Mar 2009 B2
7504040 Lijima et al. Mar 2009 B2
7513214 Okumura et al. Apr 2009 B2
7520957 Kao et al. Apr 2009 B2
7553756 Hayashi et al. Jun 2009 B2
7575007 Tang et al. Aug 2009 B2
7581511 Mardian et al. Sep 2009 B2
7604708 Wood et al. Oct 2009 B2
7611980 Wells Nov 2009 B2
7628897 Mungekar et al. Dec 2009 B2
7658799 Ishikawa et al. Feb 2010 B2
7682518 Chandrachood et al. Mar 2010 B2
7695590 Hanawa et al. Apr 2010 B2
7708859 Huang et al. May 2010 B2
7722925 White et al. May 2010 B2
7723221 Hayashi May 2010 B2
7749326 Kim et al. Jul 2010 B2
7780790 Nogami Aug 2010 B2
7785672 Choi et al. Aug 2010 B2
7790634 Munro et al. Sep 2010 B2
7806077 Lee et al. Oct 2010 B2
7806078 Yoshida Oct 2010 B2
7807578 Bencher et al. Oct 2010 B2
7825038 Ingle et al. Nov 2010 B2
7837828 Ikeda et al. Nov 2010 B2
7845309 Condrashoff et al. Dec 2010 B2
7867926 Satoh et al. Jan 2011 B2
7906818 Pekny Mar 2011 B2
7915139 Lang et al. Mar 2011 B1
7922863 Ripley Apr 2011 B2
7932181 Singh et al. Apr 2011 B2
7939422 Ingle et al. May 2011 B2
7968441 Xu Jun 2011 B2
7976631 Burrows Jul 2011 B2
7977249 Liu Jul 2011 B1
7981806 Jung Jul 2011 B2
7989365 Park et al. Aug 2011 B2
8008166 Sanchez et al. Aug 2011 B2
8048811 Feustel et al. Nov 2011 B2
8058179 Draeger et al. Nov 2011 B1
8071482 Kawada Dec 2011 B2
8074599 Choi et al. Dec 2011 B2
8076198 Lee et al. Dec 2011 B2
8083853 Choi et al. Dec 2011 B2
8114245 Ohmi et al. Feb 2012 B2
8119530 Hori et al. Feb 2012 B2
8133349 Panagopoulos Mar 2012 B1
8173228 Choi et al. May 2012 B2
8183134 Wu May 2012 B2
8187486 Liu et al. May 2012 B1
8199454 Koyama et al. Jun 2012 B2
8211808 Sapre et al. Jul 2012 B2
8216486 Dhindsa Jul 2012 B2
8222128 Sasaki et al. Jul 2012 B2
8252194 Kiehlbauch et al. Aug 2012 B2
8272346 Bettencourt et al. Sep 2012 B2
8295089 Jeong et al. Oct 2012 B2
8298627 Minami et al. Oct 2012 B2
8298959 Cheshire Oct 2012 B2
8309440 Sanchez et al. Nov 2012 B2
8312839 Baek Nov 2012 B2
8313610 Dhindsa Nov 2012 B2
8328939 Choi et al. Dec 2012 B2
8329262 Miller et al. Dec 2012 B2
8336188 Monteen Dec 2012 B2
8343306 Tanaka et al. Jan 2013 B2
8357435 Lubomirsky Jan 2013 B2
8361892 Tam et al. Jan 2013 B2
8368308 Banna et al. Feb 2013 B2
8390980 Sansoni et al. Mar 2013 B2
8427067 Espiau et al. Apr 2013 B2
8435902 Tang et al. May 2013 B2
8440523 Guillorn et al. May 2013 B1
8466073 Wang et al. Jun 2013 B2
8475674 Thadani et al. Jul 2013 B2
8480850 Tyler et al. Jul 2013 B2
8491805 Kushibiki et al. Jul 2013 B2
8501629 Tang et al. Aug 2013 B2
8506713 Takagi Aug 2013 B2
8512509 Bera et al. Aug 2013 B2
8528889 Sansoni et al. Sep 2013 B2
8540844 Hudson et al. Sep 2013 B2
8551891 Liang Oct 2013 B2
8573152 De La Llera Nov 2013 B2
8622021 Taylor et al. Jan 2014 B2
8623471 Tyler et al. Jan 2014 B2
8633423 Lin et al. Jan 2014 B2
8642481 Wang et al. Feb 2014 B2
8652298 Dhindsa et al. Feb 2014 B2
8668836 Mizukami et al. Mar 2014 B2
8679354 O'Hara Mar 2014 B2
8679982 Wang et al. Mar 2014 B2
8679983 Wang et al. Mar 2014 B2
8691023 Bao et al. Apr 2014 B2
8702902 Blom et al. Apr 2014 B2
8741778 Yang et al. Jun 2014 B2
8747610 Chen et al. Jun 2014 B2
8747680 Deshpande Jun 2014 B1
8748322 Fung et al. Jun 2014 B1
8765574 Zhang et al. Jul 2014 B2
8771536 Zhang et al. Jul 2014 B2
8771539 Zhang et al. Jul 2014 B2
8772888 Jung et al. Jul 2014 B2
8778079 Begarney et al. Jul 2014 B2
8801952 Wang et al. Aug 2014 B1
8802572 Nemani et al. Aug 2014 B2
8808563 Wang et al. Aug 2014 B2
8815720 Godet et al. Aug 2014 B2
8835316 Yin et al. Sep 2014 B2
8846163 Kao et al. Sep 2014 B2
8869742 Dhindsa Oct 2014 B2
8871651 Choi et al. Oct 2014 B1
8888087 Okabe et al. Nov 2014 B2
8894767 Goradia et al. Nov 2014 B2
8895449 Zhu et al. Nov 2014 B1
8900364 Wright Dec 2014 B2
8921234 Liu et al. Dec 2014 B2
8927390 Sapre et al. Jan 2015 B2
8932947 Han et al. Jan 2015 B1
8937017 Cheshire et al. Jan 2015 B2
8945414 Su et al. Feb 2015 B1
8946665 Shim et al. Feb 2015 B2
8946828 Sun et al. Feb 2015 B2
8951429 Liu et al. Feb 2015 B1
8956980 Chen et al. Feb 2015 B1
8969212 Ren et al. Mar 2015 B2
8970114 Busche et al. Mar 2015 B2
8980005 Carlson et al. Mar 2015 B2
8980758 Ling et al. Mar 2015 B1
8980763 Wang et al. Mar 2015 B2
8992723 Sorensen et al. Mar 2015 B2
8999656 Jirstrom et al. Apr 2015 B2
8999839 Su et al. Apr 2015 B2
8999856 Zhang et al. Apr 2015 B2
9012302 Sapre et al. Apr 2015 B2
9017481 Pettinger et al. Apr 2015 B1
9023732 Wang et al. May 2015 B2
9023734 Chen et al. May 2015 B2
9034770 Park et al. May 2015 B2
9040422 Wang et al. May 2015 B2
9064815 Zhang et al. Jun 2015 B2
9064816 Kim et al. Jun 2015 B2
9068265 Lubomirsky et al. Jun 2015 B2
9072158 Ikeda et al. Jun 2015 B2
9093371 Wang et al. Jul 2015 B2
9093389 Nemani Jul 2015 B2
9093390 Wang et al. Jul 2015 B2
9111877 Chen et al. Aug 2015 B2
9111907 Kamineni Aug 2015 B2
9114438 Hoinkis et al. Aug 2015 B2
9117855 Cho et al. Aug 2015 B2
9132436 Liang et al. Sep 2015 B2
9136273 Purayath et al. Sep 2015 B1
9144147 Yang et al. Sep 2015 B2
9153442 Wang et al. Oct 2015 B2
9159606 Purayath et al. Oct 2015 B1
9165783 Nemani et al. Oct 2015 B2
9165786 Purayath et al. Oct 2015 B1
9184055 Wang et al. Nov 2015 B2
9190290 Xue et al. Nov 2015 B2
9190293 Wang et al. Nov 2015 B2
9190302 Ni Nov 2015 B2
9202708 Chen et al. Dec 2015 B1
9209012 Chen et al. Dec 2015 B2
9236265 Korolik et al. Jan 2016 B2
9236266 Zhang et al. Jan 2016 B2
9240315 Hsieh et al. Jan 2016 B1
9245762 Zhang et al. Jan 2016 B2
9263278 Purayath et al. Feb 2016 B2
9267739 Chen et al. Feb 2016 B2
9269590 Luere et al. Feb 2016 B2
9275834 Park et al. Mar 2016 B1
9281384 Takeguchi Mar 2016 B2
9287095 Nguyen et al. Mar 2016 B2
9287134 Wang et al. Mar 2016 B2
9293568 Ko Mar 2016 B2
9299537 Kobayashi et al. Mar 2016 B2
9299538 Kobayashi et al. Mar 2016 B2
9299539 Makhratchev Mar 2016 B2
9299575 Park et al. Mar 2016 B2
9299582 Ingle et al. Mar 2016 B2
9299583 Wang et al. Mar 2016 B1
9309598 Wang et al. Apr 2016 B2
9324576 Zhang et al. Apr 2016 B2
9343272 Pandit et al. May 2016 B1
9343327 Zhang et al. May 2016 B2
9349605 Xu et al. May 2016 B1
9355856 Wang et al. May 2016 B2
9355862 Pandit et al. May 2016 B2
9355863 Chen et al. May 2016 B2
9355922 Park et al. May 2016 B2
9362130 Ingle et al. Jun 2016 B2
9362163 Danek et al. Jun 2016 B2
9368364 Park et al. Jun 2016 B2
9373517 Yang et al. Jun 2016 B2
9373522 Wang et al. Jun 2016 B1
9378969 Hsu et al. Jun 2016 B2
9378978 Purayath et al. Jun 2016 B2
9384997 Ren et al. Jul 2016 B2
9385028 Nemani et al. Jul 2016 B2
9390937 Chen et al. Jul 2016 B2
9396961 Arghavani et al. Jul 2016 B2
9396989 Purayath et al. Jul 2016 B2
9406523 Chen et al. Aug 2016 B2
9412608 Wang et al. Aug 2016 B2
9412752 Yeh et al. Aug 2016 B1
9418858 Wang et al. Aug 2016 B2
9425041 Berry et al. Aug 2016 B2
9425057 Cho et al. Aug 2016 B2
9425058 Kim et al. Aug 2016 B2
9431268 Lill et al. Aug 2016 B2
9431414 Jang et al. Aug 2016 B2
9343358 Montgomery Sep 2016 B1
9437451 Chen et al. Sep 2016 B2
9443749 Smith Sep 2016 B2
9449843 Korolik et al. Sep 2016 B1
9449845 Liu et al. Sep 2016 B2
9449846 Liu et al. Sep 2016 B2
9449850 Wang et al. Sep 2016 B2
9460959 Xie et al. Oct 2016 B1
9466469 Khaja Oct 2016 B2
9472412 Zhang et al. Oct 2016 B2
9472417 Ingle et al. Oct 2016 B2
9478432 Chen et al. Oct 2016 B2
9478433 Zhou et al. Oct 2016 B1
9478434 Wang et al. Oct 2016 B2
9493879 Hoinkis et al. Nov 2016 B2
9496167 Purayath et al. Nov 2016 B2
9499898 Nguyen et al. Nov 2016 B2
9502258 Xue et al. Nov 2016 B2
9508529 Valcore et al. Nov 2016 B2
9520303 Wang et al. Dec 2016 B2
9534724 Jiang et al. Jan 2017 B2
9543163 Ling et al. Jan 2017 B2
9564296 Kobayashi et al. Feb 2017 B2
9564338 Zhang et al. Feb 2017 B1
9576788 Liu et al. Feb 2017 B2
9576809 Korolik et al. Feb 2017 B2
9607856 Wang et al. Mar 2017 B2
9613822 Chen et al. Apr 2017 B2
9659753 Cho et al. May 2017 B2
9659791 Wang et al. May 2017 B2
9659792 Wang et al. May 2017 B2
9666449 Koval et al. May 2017 B2
9691645 Benjaminson et al. Jun 2017 B2
9704723 Wang et al. Jul 2017 B2
9711366 Ingle et al. Jul 2017 B2
9721789 Yang et al. Aug 2017 B1
9728437 Tran et al. Aug 2017 B2
9741593 Benjaminson et al. Aug 2017 B2
9754800 Zhang et al. Sep 2017 B2
9768034 Xu et al. Sep 2017 B1
9773648 Cho et al. Sep 2017 B2
9773695 Purayath et al. Sep 2017 B2
9779956 Zhang et al. Oct 2017 B1
9812462 Pang et al. Nov 2017 B1
9822009 Kagaya et al. Nov 2017 B2
9831097 Ingle et al. Nov 2017 B2
9837249 Kobayashi et al. Dec 2017 B2
9837284 Chen et al. Dec 2017 B2
9837286 Yang et al. Dec 2017 B2
9842744 Zhang et al. Dec 2017 B2
9865484 Citla et al. Jan 2018 B1
9881805 Li et al. Jan 2018 B2
9885117 Lubomirsky et al. Feb 2018 B2
9887096 Park et al. Feb 2018 B2
9903020 Kim et al. Feb 2018 B2
9934942 Lubomirsky Apr 2018 B1
9941097 Yamazawa Apr 2018 B2
9947549 Park et al. Apr 2018 B1
9960045 Purayath et al. May 2018 B1
9966240 Park et al. May 2018 B2
9978564 Liang et al. May 2018 B2
9991134 Wang et al. Jun 2018 B2
10026621 Ko et al. Jul 2018 B2
10032606 Yang et al. Jul 2018 B2
10043674 Korolik et al. Aug 2018 B1
10043684 Arnepalli et al. Aug 2018 B1
10049891 Wang et al. Aug 2018 B1
10062578 Zhang et al. Aug 2018 B2
10062579 Chen et al. Aug 2018 B2
10062585 Lubomirsky Aug 2018 B2
10062587 Chen et al. Aug 2018 B2
10083830 Seino et al. Sep 2018 B2
10147620 Benjaminson et al. Dec 2018 B2
10147736 Linuma Dec 2018 B2
10269541 Stowell et al. Apr 2019 B2
10319739 Purayath Jun 2019 B2
20010003014 Yuda Jun 2001 A1
20010006093 Tabuchi et al. Jul 2001 A1
20010008803 Takamatsu et al. Jul 2001 A1
20010015175 Masuda et al. Aug 2001 A1
20010015261 Kobayashi et al. Aug 2001 A1
20010023741 Collison et al. Sep 2001 A1
20010028093 Yamazaki et al. Oct 2001 A1
20010028922 Sandhu Oct 2001 A1
20010029891 Oh et al. Oct 2001 A1
20010030366 Nakano et al. Oct 2001 A1
20010034106 Moise et al. Oct 2001 A1
20010034121 Fu et al. Oct 2001 A1
20010035124 Okayama et al. Nov 2001 A1
20010036706 Kitamura Nov 2001 A1
20010037856 Park Nov 2001 A1
20010037941 Thompson Nov 2001 A1
20010039921 Rolfson et al. Nov 2001 A1
20010042512 Xu et al. Nov 2001 A1
20010042799 Kim et al. Nov 2001 A1
20010045269 Yamada Nov 2001 A1
20010047760 Moslehi Dec 2001 A1
20010053585 Kikuchi et al. Dec 2001 A1
20010053610 Athavale et al. Dec 2001 A1
20010054381 Umotoy et al. Dec 2001 A1
20010054387 Frankel et al. Dec 2001 A1
20020000202 Yuda et al. Jan 2002 A1
20020001778 Latchford et al. Jan 2002 A1
20020009560 Ozono Jan 2002 A1
20020009885 Brankner et al. Jan 2002 A1
20020011210 Satoh et al. Jan 2002 A1
20020011214 Kamarehi et al. Jan 2002 A1
20020016080 Khan et al. Feb 2002 A1
20020016085 Huang et al. Feb 2002 A1
20020020429 Selbrede et al. Feb 2002 A1
20020023899 Khater et al. Feb 2002 A1
20020028582 Nallan et al. Mar 2002 A1
20020028585 Chung et al. Mar 2002 A1
20020029747 Powell et al. Mar 2002 A1
20020033233 Savas Mar 2002 A1
20020036143 Segawa et al. Mar 2002 A1
20020040764 Kwan et al. Apr 2002 A1
20020040766 Takahashi et al. Apr 2002 A1
20020042192 Tanaka et al. Apr 2002 A1
20020043690 Doyle et al. Apr 2002 A1
20020045966 Lee et al. Apr 2002 A1
20020046991 Smith et al. Apr 2002 A1
20020048963 Campbell et al. Apr 2002 A1
20020054962 Huang May 2002 A1
20020062954 Getchel et al. May 2002 A1
20020069820 Yudovsky Jun 2002 A1
20020070414 Drescher et al. Jun 2002 A1
20020073925 Noble et al. Jun 2002 A1
20020074573 Takeuchi et al. Jun 2002 A1
20020075624 Wang et al. Jun 2002 A1
20020086501 O'Donnell et al. Jul 2002 A1
20020090781 Skotnicki et al. Jul 2002 A1
20020090835 Chakravarti et al. Jul 2002 A1
20020094378 O'Donnell et al. Jul 2002 A1
20020094591 Sill et al. Jul 2002 A1
20020096493 Hattori Jul 2002 A1
20020098681 Hu et al. Jul 2002 A1
20020106845 Chao et al. Aug 2002 A1
20020112819 Kamarehi et al. Aug 2002 A1
20020124867 Kim et al. Sep 2002 A1
20020129769 Kim et al. Sep 2002 A1
20020129902 Babayan et al. Sep 2002 A1
20020144657 Chiang et al. Oct 2002 A1
20020153808 Skotnicki et al. Oct 2002 A1
20020164885 Lill et al. Nov 2002 A1
20020170678 Hayashi et al. Nov 2002 A1
20020177322 Li et al. Nov 2002 A1
20020179248 Kabansky et al. Dec 2002 A1
20020182878 Hirose et al. Dec 2002 A1
20020185226 Lea et al. Dec 2002 A1
20020187280 Johnson et al. Dec 2002 A1
20020187655 Tan et al. Dec 2002 A1
20020197823 Yoo et al. Dec 2002 A1
20030000647 Yudovsky et al. Jan 2003 A1
20030003757 Naltan et al. Jan 2003 A1
20030007910 Lazarovich et al. Jan 2003 A1
20030010645 Ting et al. Jan 2003 A1
20030015515 Ito et al. Jan 2003 A1
20030019428 Ku et al. Jan 2003 A1
20030019580 Strang Jan 2003 A1
20030026060 Hiramatsu et al. Feb 2003 A1
20030029566 Roth Feb 2003 A1
20030029567 Dhindsa et al. Feb 2003 A1
20030029715 Yu et al. Feb 2003 A1
20030031905 Saito et al. Feb 2003 A1
20030032284 Enomoto et al. Feb 2003 A1
20030038127 Liu et al. Feb 2003 A1
20030038305 Wasshuber Feb 2003 A1
20030054608 Tseng et al. Mar 2003 A1
20030066482 Pokharna et al. Apr 2003 A1
20030071035 Brailove Apr 2003 A1
20030072639 White et al. Apr 2003 A1
20030075808 Inoue et al. Apr 2003 A1
20030077857 Xia et al. Apr 2003 A1
20030077909 Jiwari Apr 2003 A1
20030079686 Chen et al. May 2003 A1
20030087488 Fink et al. May 2003 A1
20030087531 Kang et al. May 2003 A1
20030091938 Fairbairn et al. May 2003 A1
20030094134 Minami et al. May 2003 A1
20030098125 An May 2003 A1
20030101938 Ronsse et al. Jun 2003 A1
20030109143 Hsieh et al. Jun 2003 A1
20030116087 Nguyen et al. Jun 2003 A1
20030116439 Seo et al. Jun 2003 A1
20030119328 Fujisato Jun 2003 A1
20030121608 Chen et al. Jul 2003 A1
20030121609 Ohmi et al. Jul 2003 A1
20030124465 Lee et al. Jul 2003 A1
20030124842 Hytros et al. Jul 2003 A1
20030127049 Han et al. Jul 2003 A1
20030127740 Hsu et al. Jul 2003 A1
20030129106 Sorensen et al. Jul 2003 A1
20030129827 Lee et al. Jul 2003 A1
20030132319 Hytros et al. Jul 2003 A1
20030136520 Yudovsky et al. Jul 2003 A1
20030140844 Maa et al. Jul 2003 A1
20030143328 Chen et al. Jul 2003 A1
20030148035 Lingampalli Aug 2003 A1
20030150530 Lin et al. Aug 2003 A1
20030152691 Baude Aug 2003 A1
20030159307 Sago et al. Aug 2003 A1
20030164226 Kanno et al. Sep 2003 A1
20030168439 Kanno et al. Sep 2003 A1
20030170945 Igeta et al. Sep 2003 A1
20030173333 Wang et al. Sep 2003 A1
20030173347 Guiver Sep 2003 A1
20030173675 Watanabe Sep 2003 A1
20030181040 Ivanov et al. Sep 2003 A1
20030183244 Rossman Oct 2003 A1
20030190426 Padhi et al. Oct 2003 A1
20030196760 Tyler et al. Oct 2003 A1
20030199170 Li Oct 2003 A1
20030200929 Otsuki Oct 2003 A1
20030201764 Jafari et al. Oct 2003 A1
20030205329 Gujer et al. Nov 2003 A1
20030205479 Lin et al. Nov 2003 A1
20030209323 Yokogaki et al. Nov 2003 A1
20030215570 Seutter et al. Nov 2003 A1
20030215963 AmRhein et al. Nov 2003 A1
20030216044 Lin et al. Nov 2003 A1
20030221780 Lei et al. Dec 2003 A1
20030224217 Byun et al. Dec 2003 A1
20030224617 Baek et al. Dec 2003 A1
20030230385 Bach et al. Dec 2003 A1
20040002221 O'Donnell et al. Jan 2004 A1
20040003828 Jackson Jan 2004 A1
20040005726 Huang Jan 2004 A1
20040018304 Chung et al. Jan 2004 A1
20040020801 Solling Feb 2004 A1
20040026371 Nguyen et al. Feb 2004 A1
20040033678 Arghavani et al. Feb 2004 A1
20040033684 Li Feb 2004 A1
20040050328 Kumagai et al. Mar 2004 A1
20040058070 Takeuchi et al. Mar 2004 A1
20040058293 Nguyen et al. Mar 2004 A1
20040060514 Janakiraman et al. Apr 2004 A1
20040061447 Saigusa et al. Apr 2004 A1
20040069225 Fairbairn et al. Apr 2004 A1
20040070346 Choi Apr 2004 A1
20040072446 Liu et al. Apr 2004 A1
20040076529 Gnauck et al. Apr 2004 A1
20040083967 Yuda et al. May 2004 A1
20040087139 Yeh et al. May 2004 A1
20040092063 Okumura May 2004 A1
20040099285 Wang et al. May 2004 A1
20040099378 Kim et al. May 2004 A1
20040101667 O'Loughlin et al. May 2004 A1
20040103844 Chou et al. Jun 2004 A1
20040107908 Collins et al. Jun 2004 A1
20040108067 Fischione et al. Jun 2004 A1
20040108068 Senzaki et al. Jun 2004 A1
20040115876 Goundar et al. Jun 2004 A1
20040115947 Fink et al. Jun 2004 A1
20040124280 Shih et al. Jul 2004 A1
20040129671 Ji et al. Jul 2004 A1
20040137161 Segawa et al. Jul 2004 A1
20040140053 Srivastava et al. Jul 2004 A1
20040144311 Chen et al. Jul 2004 A1
20040144490 Zhao et al. Jul 2004 A1
20040147126 Yamashita et al. Jul 2004 A1
20040149223 Collison et al. Aug 2004 A1
20040149387 Kim et al. Aug 2004 A1
20040149394 Doan et al. Aug 2004 A1
20040152342 Li Aug 2004 A1
20040154535 Chen et al. Aug 2004 A1
20040157444 Chiu Aug 2004 A1
20040161921 Ryu Aug 2004 A1
20040163601 Kadotani et al. Aug 2004 A1
20040175913 Johnson et al. Sep 2004 A1
20040175929 Schmitt et al. Sep 2004 A1
20040182315 Laflamme et al. Sep 2004 A1
20040187787 Dawson Sep 2004 A1
20040192032 Ohmori et al. Sep 2004 A1
20040194799 Kim et al. Oct 2004 A1
20040195208 Pavel et al. Oct 2004 A1
20040195216 Strang Oct 2004 A1
20040200499 Harvey Oct 2004 A1
20040211357 Gadgil et al. Oct 2004 A1
20040219723 Peng et al. Nov 2004 A1
20040219737 Quon Nov 2004 A1
20040219789 Wood et al. Nov 2004 A1
20040221809 Ohmi et al. Nov 2004 A1
20040231706 Bhatnagar et al. Nov 2004 A1
20040237897 Hanawa et al. Dec 2004 A1
20040238123 Becknell et al. Dec 2004 A1
20040259367 Constantine et al. Dec 2004 A1
20040263827 Xu Dec 2004 A1
20050000430 Jang et al. Jan 2005 A1
20050000432 Keller et al. Jan 2005 A1
20050001276 Gao et al. Jan 2005 A1
20050003676 Ho et al. Jan 2005 A1
20050009340 Saijo et al. Jan 2005 A1
20050009358 Choi et al. Jan 2005 A1
20050026430 Kim et al. Feb 2005 A1
20050026431 Kazumi et al. Feb 2005 A1
20050035455 Hu et al. Feb 2005 A1
20050039679 Kleshock Feb 2005 A1
20050051094 Schaepkens et al. Mar 2005 A1
20050054167 Choi et al. Mar 2005 A1
20050056218 Sun et al. Mar 2005 A1
20050073051 Yamamoto et al. Apr 2005 A1
20050079706 Kumar et al. Apr 2005 A1
20050087517 Ott et al. Apr 2005 A1
20050090078 Ishihara Apr 2005 A1
20050090120 Hasegawa et al. Apr 2005 A1
20050098111 Shimizu et al. May 2005 A1
20050103267 Hur et al. May 2005 A1
20050105991 Hofmeister et al. May 2005 A1
20050109279 Suzuki May 2005 A1
20050112876 Wu May 2005 A1
20050112901 Ji et al. May 2005 A1
20050123690 Derderian et al. Jun 2005 A1
20050133849 Jeon et al. Jun 2005 A1
20050136188 Chang Jun 2005 A1
20050145341 Suzuki Jul 2005 A1
20050164479 Perng et al. Jul 2005 A1
20050167394 Liu et al. Aug 2005 A1
20050176258 Hirose et al. Aug 2005 A1
20050178746 Gorin Aug 2005 A1
20050181588 Kim Aug 2005 A1
20050183666 Tsuji et al. Aug 2005 A1
20050194094 Yasaka Sep 2005 A1
20050196967 Savas et al. Sep 2005 A1
20050199489 Stevens et al. Sep 2005 A1
20050205110 Kao et al. Sep 2005 A1
20050205862 Koemtzopoulos et al. Sep 2005 A1
20050208215 Eguchi et al. Sep 2005 A1
20050208217 Shinriki et al. Sep 2005 A1
20050214477 Hanawa et al. Sep 2005 A1
20050217582 Kim et al. Oct 2005 A1
20050218507 Kao et al. Oct 2005 A1
20050219786 Brown et al. Oct 2005 A1
20050221552 Kao et al. Oct 2005 A1
20050224181 Merry et al. Oct 2005 A1
20050229848 Shinriki et al. Oct 2005 A1
20050230350 Kao et al. Oct 2005 A1
20050236694 Wu et al. Oct 2005 A1
20050238807 Lin et al. Oct 2005 A1
20050239282 Chen et al. Oct 2005 A1
20050241579 Kidd Nov 2005 A1
20050241583 Buechel et al. Nov 2005 A1
20050241763 Huang et al. Nov 2005 A1
20050251990 Choi et al. Nov 2005 A1
20050257890 Park et al. Nov 2005 A1
20050266622 Arghavani et al. Dec 2005 A1
20050266650 Ahn et al. Dec 2005 A1
20050266691 Gu et al. Dec 2005 A1
20050269030 Kent et al. Dec 2005 A1
20050274324 Takahashi et al. Dec 2005 A1
20050279454 Snijders Dec 2005 A1
20050283321 Yue et al. Dec 2005 A1
20050287688 Won et al. Dec 2005 A1
20050287755 Bachmann Dec 2005 A1
20050287771 Seamons et al. Dec 2005 A1
20060000802 Kumar et al. Jan 2006 A1
20060000805 Todorow et al. Jan 2006 A1
20060005856 Sun et al. Jan 2006 A1
20060005930 Ikeda et al. Jan 2006 A1
20060006057 Laermer Jan 2006 A1
20060008676 Ebata et al. Jan 2006 A1
20060011298 Lim et al. Jan 2006 A1
20060011299 Condrashoff et al. Jan 2006 A1
20060016783 Wu et al. Jan 2006 A1
20060019456 Bu et al. Jan 2006 A1
20060019477 Hanawa et al. Jan 2006 A1
20060019486 Yu et al. Jan 2006 A1
20060021574 Armour et al. Feb 2006 A1
20060021701 Tobe et al. Feb 2006 A1
20060021703 Umotoy et al. Feb 2006 A1
20060024954 Wu et al. Feb 2006 A1
20060024956 Zhijian et al. Feb 2006 A1
20060032833 Kawaguchi et al. Feb 2006 A1
20060033678 Lubomirsky et al. Feb 2006 A1
20060040055 Nguyen et al. Feb 2006 A1
20060043066 Kamp Mar 2006 A1
20060046412 Nguyen et al. Mar 2006 A1
20060046419 Sandhu et al. Mar 2006 A1
20060046470 Becknell Mar 2006 A1
20060051966 Or et al. Mar 2006 A1
20060051968 Joshi et al. Mar 2006 A1
20060054184 Mozetic et al. Mar 2006 A1
20060054280 Jang Mar 2006 A1
20060057828 Omura et al. Mar 2006 A1
20060060942 Minixhofer et al. Mar 2006 A1
20060065629 Chen et al. Mar 2006 A1
20060073349 Aihara et al. Apr 2006 A1
20060076108 Holland et al. Apr 2006 A1
20060087644 McMillin et al. Apr 2006 A1
20060090700 Satoh et al. May 2006 A1
20060093756 Rajagopalan et al. May 2006 A1
20060097397 Russell et al. May 2006 A1
20060102076 Smith et al. May 2006 A1
20060102587 Kimura May 2006 A1
20060113038 Gondhalekar et al. Jun 2006 A1
20060118178 Desbiolles et al. Jun 2006 A1
20060118240 Holber et al. Jun 2006 A1
20060121724 Yue et al. Jun 2006 A1
20060124151 Yamasaki et al. Jun 2006 A1
20060124242 Kanarik et al. Jun 2006 A1
20060130971 Chang et al. Jun 2006 A1
20060151115 Kim et al. Jul 2006 A1
20060157449 Takahashi et al. Jul 2006 A1
20060162661 Jung et al. Jul 2006 A1
20060166107 Chen et al. Jul 2006 A1
20060166515 Karim et al. Jul 2006 A1
20060169327 Shajii et al. Aug 2006 A1
20060169410 Maeda et al. Aug 2006 A1
20060178008 Yeh et al. Aug 2006 A1
20060183270 Humpston Aug 2006 A1
20060185592 Matsuura Aug 2006 A1
20060191479 Mizukami et al. Aug 2006 A1
20060191637 Zajac et al. Aug 2006 A1
20060207504 Hasebe et al. Sep 2006 A1
20060207595 Ohmi et al. Sep 2006 A1
20060207971 Moriya et al. Sep 2006 A1
20060210713 Brcka Sep 2006 A1
20060210723 Ishizaka Sep 2006 A1
20060215347 Wakabayashi et al. Sep 2006 A1
20060216878 Lee Sep 2006 A1
20060219360 Iwasaki Oct 2006 A1
20060222481 Foree Oct 2006 A1
20060226121 Aoi Oct 2006 A1
20060228889 Edelberg et al. Oct 2006 A1
20060240661 Annapragada et al. Oct 2006 A1
20060244107 Sugihara Nov 2006 A1
20060245852 Iwabuchi Nov 2006 A1
20060246217 Weidman et al. Nov 2006 A1
20060251800 Weidman et al. Nov 2006 A1
20060251801 Weidman et al. Nov 2006 A1
20060252252 Zhu et al. Nov 2006 A1
20060252265 Jin et al. Nov 2006 A1
20060254716 Mosden et al. Nov 2006 A1
20060260750 Rueger Nov 2006 A1
20060261490 Su et al. Nov 2006 A1
20060264043 Stewart et al. Nov 2006 A1
20060266288 Choi Nov 2006 A1
20060285270 Lee Dec 2006 A1
20060286774 Singh et al. Dec 2006 A1
20060289384 Pavel et al. Dec 2006 A1
20060292846 Pinto et al. Dec 2006 A1
20070022952 Ritchie et al. Feb 2007 A1
20070022954 Ilzuka et al. Feb 2007 A1
20070025907 Rezeq Feb 2007 A1
20070039548 Johnson Feb 2007 A1
20070048977 Lee et al. Mar 2007 A1
20070051471 Kawaguchi et al. Mar 2007 A1
20070056925 Liu et al. Mar 2007 A1
20070062453 Ishikawa Mar 2007 A1
20070066084 Wajda et al. Mar 2007 A1
20070071888 Shanmugasundram et al. Mar 2007 A1
20070072408 Enomoto et al. Mar 2007 A1
20070077737 Kobayashi Apr 2007 A1
20070079758 Holland et al. Apr 2007 A1
20070090325 Hwang et al. Apr 2007 A1
20070099428 Shamiryan et al. May 2007 A1
20070099431 Li May 2007 A1
20070099438 Ye et al. May 2007 A1
20070107750 Sawin et al. May 2007 A1
20070108404 Stewart et al. May 2007 A1
20070111519 Lubomirsky et al. May 2007 A1
20070117396 Wu et al. May 2007 A1
20070119370 Ma et al. May 2007 A1
20070119371 Ma et al. May 2007 A1
20070123051 Arghavani et al. May 2007 A1
20070128864 Ma Jun 2007 A1
20070128876 Fukiage Jun 2007 A1
20070131274 Stollwerck et al. Jun 2007 A1
20070145023 Holber et al. Jun 2007 A1
20070148349 Fukada Jun 2007 A1
20070154838 Lee Jul 2007 A1
20070163440 Kim et al. Jul 2007 A1
20070169703 Elliot et al. Jul 2007 A1
20070175861 Hwang et al. Aug 2007 A1
20070181057 Lam et al. Aug 2007 A1
20070193515 Jeon et al. Aug 2007 A1
20070197028 Byun et al. Aug 2007 A1
20070207275 Nowak et al. Sep 2007 A1
20070212288 Holst Sep 2007 A1
20070221620 Sakthivel et al. Sep 2007 A1
20070227554 Satoh et al. Oct 2007 A1
20070231109 Pak et al. Oct 2007 A1
20070232071 Balseanu et al. Oct 2007 A1
20070235134 Limuro Oct 2007 A1
20070235136 Enomoto et al. Oct 2007 A1
20070238199 Yamashita Oct 2007 A1
20070238321 Futase et al. Oct 2007 A1
20070243685 Jiang et al. Oct 2007 A1
20070243714 Shin et al. Oct 2007 A1
20070254169 Kamins et al. Nov 2007 A1
20070258186 Matyushkin et al. Nov 2007 A1
20070259467 Tweet et al. Nov 2007 A1
20070264820 Liu Nov 2007 A1
20070266946 Choi Nov 2007 A1
20070272154 Amikura et al. Nov 2007 A1
20070277734 Lubomirsky et al. Dec 2007 A1
20070280816 Kurita et al. Dec 2007 A1
20070281106 Lubomirsky et al. Dec 2007 A1
20070284044 Matsumoto et al. Dec 2007 A1
20070284344 Todorov et al. Dec 2007 A1
20070287292 Li et al. Dec 2007 A1
20070296967 Gupta et al. Dec 2007 A1
20080003836 Nishimura et al. Jan 2008 A1
20080011424 Yin et al. Jan 2008 A1
20080017104 Matyushkin et al. Jan 2008 A1
20080020570 Naik Jan 2008 A1
20080029032 Sun et al. Feb 2008 A1
20080035608 Thomas et al. Feb 2008 A1
20080044593 Seo et al. Feb 2008 A1
20080044990 Lee Feb 2008 A1
20080050538 Hirata Feb 2008 A1
20080063810 Park et al. Mar 2008 A1
20080075668 Goldstein Mar 2008 A1
20080081483 Wu Apr 2008 A1
20080085604 Hoshino et al. Apr 2008 A1
20080089001 Parkhe et al. Apr 2008 A1
20080099147 Myo et al. May 2008 A1
20080099431 Kumar et al. May 2008 A1
20080099876 Seto May 2008 A1
20080100222 Lewington et al. May 2008 A1
20080102570 Fischer et al. May 2008 A1
20080102640 Hassan et al. May 2008 A1
20080102646 Kawaguchi et al. May 2008 A1
20080104782 Hughes May 2008 A1
20080105555 Iwazaki et al. May 2008 A1
20080115726 Ingle et al. May 2008 A1
20080121970 Aritome May 2008 A1
20080124937 Xu et al. May 2008 A1
20080141941 Augustino et al. Jun 2008 A1
20080142831 Su Jun 2008 A1
20080153306 Cho et al. Jun 2008 A1
20080156631 Fair et al. Jul 2008 A1
20080156771 Jeon et al. Jul 2008 A1
20080157225 Datta et al. Jul 2008 A1
20080160210 Yang et al. Jul 2008 A1
20080169588 Shih et al. Jul 2008 A1
20080171407 Nakabayashi et al. Jul 2008 A1
20080173906 Zhu Jul 2008 A1
20080176412 Komeda Jul 2008 A1
20080178797 Fodor et al. Jul 2008 A1
20080178805 Paterson et al. Jul 2008 A1
20080182381 Kiyotoshi Jul 2008 A1
20080182382 Ingle et al. Jul 2008 A1
20080182383 Lee et al. Jul 2008 A1
20080193673 Paterson et al. Aug 2008 A1
20080196666 Toshima Aug 2008 A1
20080202688 Wu et al. Aug 2008 A1
20080202892 Smith et al. Aug 2008 A1
20080213496 Sun et al. Sep 2008 A1
20080216901 Chamberlain et al. Sep 2008 A1
20080216958 Goto et al. Sep 2008 A1
20080230519 Takahashi Sep 2008 A1
20080233709 Conti et al. Sep 2008 A1
20080236751 Aramaki et al. Oct 2008 A1
20080254635 Benzel et al. Oct 2008 A1
20080261404 Kozuka et al. Oct 2008 A1
20080264337 Sano et al. Oct 2008 A1
20080268645 Kao et al. Oct 2008 A1
20080292798 Huh et al. Nov 2008 A1
20080293248 Park et al. Nov 2008 A1
20080317965 Son et al. Dec 2008 A1
20090000743 Iizuka Jan 2009 A1
20090001480 Cheng Jan 2009 A1
20090004849 Eun Jan 2009 A1
20090004873 Yang Jan 2009 A1
20090014127 Shah et al. Jan 2009 A1
20090014323 Yendler et al. Jan 2009 A1
20090014324 Kawaguchi et al. Jan 2009 A1
20090017227 Fu et al. Jan 2009 A1
20090022633 Tomosue et al. Jan 2009 A1
20090036292 Sun et al. Feb 2009 A1
20090045167 Maruyama Feb 2009 A1
20090061640 Wong et al. Mar 2009 A1
20090072401 Arnold et al. Mar 2009 A1
20090075409 Ueno et al. Mar 2009 A1
20090081878 Dhindsa Mar 2009 A1
20090084317 Wu et al. Apr 2009 A1
20090087960 Cho et al. Apr 2009 A1
20090087979 Raghuram et al. Apr 2009 A1
20090095221 Tam et al. Apr 2009 A1
20090095222 Tam et al. Apr 2009 A1
20090095621 Kao et al. Apr 2009 A1
20090098276 Burrows Apr 2009 A1
20090098706 Kim et al. Apr 2009 A1
20090104738 Ring et al. Apr 2009 A1
20090104782 Lu et al. Apr 2009 A1
20090111280 Kao et al. Apr 2009 A1
20090117270 Yamasaki et al. May 2009 A1
20090120364 Suarez et al. May 2009 A1
20090120464 Rasheed et al. May 2009 A1
20090120582 Koshimizu May 2009 A1
20090140738 Desvaux et al. Jun 2009 A1
20090159213 Bera et al. Jun 2009 A1
20090159566 Brillhart et al. Jun 2009 A1
20090159588 Morioka et al. Jun 2009 A1
20090162647 Sun et al. Jun 2009 A1
20090170221 Jacques et al. Jul 2009 A1
20090170331 Cheng et al. Jul 2009 A1
20090179300 Arai Jul 2009 A1
20090189246 Wu et al. Jul 2009 A1
20090189287 Yang et al. Jul 2009 A1
20090191711 Rui et al. Jul 2009 A1
20090194233 Tamura Aug 2009 A1
20090194810 Kiyotoshi et al. Aug 2009 A1
20090197418 Sago Aug 2009 A1
20090202721 Nogami et al. Aug 2009 A1
20090212804 Yamada et al. Aug 2009 A1
20090214825 Sun et al. Aug 2009 A1
20090223928 Colpo Sep 2009 A1
20090226633 Laflamme, Jr. et al. Sep 2009 A1
20090236314 Chen Sep 2009 A1
20090253222 Morisawa et al. Oct 2009 A1
20090255902 Satoh et al. Oct 2009 A1
20090258162 Furuta et al. Oct 2009 A1
20090269934 Kao et al. Oct 2009 A1
20090274590 Willwerth et al. Nov 2009 A1
20090275146 Takano et al. Nov 2009 A1
20090275205 Kiehlbauch et al. Nov 2009 A1
20090275206 Katz et al. Nov 2009 A1
20090277587 Lubomirsky et al. Nov 2009 A1
20090277874 Rui et al. Nov 2009 A1
20090280650 Lubomirsky et al. Nov 2009 A1
20090286400 Heo et al. Nov 2009 A1
20090286405 Okesaku et al. Nov 2009 A1
20090293809 Cho et al. Dec 2009 A1
20090294898 Feustel et al. Dec 2009 A1
20090298256 Chen et al. Dec 2009 A1
20090302005 Kool et al. Dec 2009 A1
20090314309 Sankarakrishnan et al. Dec 2009 A1
20090314433 Hoffman et al. Dec 2009 A1
20090317978 Higashi Dec 2009 A1
20090320756 Tanaka Dec 2009 A1
20100000683 Kadkhodayan et al. Jan 2010 A1
20100003406 Lam et al. Jan 2010 A1
20100003824 Kadkhodayan et al. Jan 2010 A1
20100006032 Hinckley et al. Jan 2010 A1
20100006543 Sawada et al. Jan 2010 A1
20100018648 Collins et al. Jan 2010 A1
20100022030 Ditizio Jan 2010 A1
20100025370 Dieguez-Campo et al. Feb 2010 A1
20100037821 Nogami Feb 2010 A1
20100039747 Sansoni Feb 2010 A1
20100047080 Bruce Feb 2010 A1
20100048022 Kubota Feb 2010 A1
20100048027 Cheng et al. Feb 2010 A1
20100055408 Lee et al. Mar 2010 A1
20100055917 Kim Mar 2010 A1
20100059889 Gosset et al. Mar 2010 A1
20100062603 Ganguly et al. Mar 2010 A1
20100072172 Ui et al. Mar 2010 A1
20100075503 Bencher Mar 2010 A1
20100081285 Chen et al. Apr 2010 A1
20100089533 Ueda et al. Apr 2010 A1
20100093151 Arghavani et al. Apr 2010 A1
20100093168 Naik Apr 2010 A1
20100096367 Jeon et al. Apr 2010 A1
20100098882 Lubomirsky et al. Apr 2010 A1
20100099236 Kwon et al. Apr 2010 A1
20100099263 Kao et al. Apr 2010 A1
20100101727 Ji Apr 2010 A1
20100105209 Winniczek et al. Apr 2010 A1
20100116788 Singh et al. May 2010 A1
20100119843 Sun et al. May 2010 A1
20100129974 Futase et al. May 2010 A1
20100130001 Noguchi May 2010 A1
20100139889 Kurita et al. Jun 2010 A1
20100144140 Chandrashekar et al. Jun 2010 A1
20100147219 Hsieh et al. Jun 2010 A1
20100151149 Ovshinsky Jun 2010 A1
20100164422 Shu et al. Jul 2010 A1
20100173499 Tao et al. Jul 2010 A1
20100178748 Subramanian Jul 2010 A1
20100178755 Lee et al. Jul 2010 A1
20100180819 Hatanaka et al. Jul 2010 A1
20100183825 Becker et al. Jul 2010 A1
20100187534 Nishi et al. Jul 2010 A1
20100187588 Kim et al. Jul 2010 A1
20100187694 Yu et al. Jul 2010 A1
20100190352 Jaiswal Jul 2010 A1
20100197143 Nishimura Aug 2010 A1
20100203739 Becker et al. Aug 2010 A1
20100206483 Sorensen et al. Aug 2010 A1
20100207195 Fukuzumi et al. Aug 2010 A1
20100207205 Grebs et al. Aug 2010 A1
20100212594 Hara et al. Aug 2010 A1
20100213172 Wilson Aug 2010 A1
20100224322 Sui et al. Sep 2010 A1
20100224324 Kasai Sep 2010 A1
20100240205 Son Sep 2010 A1
20100243165 Um Sep 2010 A1
20100243606 Koshimizu Sep 2010 A1
20100244204 Matsuoka et al. Sep 2010 A1
20100248488 Agarwal et al. Sep 2010 A1
20100252068 Kannan et al. Oct 2010 A1
20100258913 Lue Oct 2010 A1
20100267224 Choi et al. Oct 2010 A1
20100267248 Ma et al. Oct 2010 A1
20100273290 Kryliouk Oct 2010 A1
20100273291 Kryliouk et al. Oct 2010 A1
20100288369 Chang et al. Nov 2010 A1
20100294199 Tran et al. Nov 2010 A1
20100310785 Sasakawa et al. Dec 2010 A1
20100314005 Saito et al. Dec 2010 A1
20100317197 Lind et al. Dec 2010 A1
20100330814 Yokota et al. Dec 2010 A1
20110005607 Desbiolles et al. Jan 2011 A1
20110005684 Hayami et al. Jan 2011 A1
20110008950 Xu Jan 2011 A1
20110011338 Chuc et al. Jan 2011 A1
20110034035 Liang et al. Feb 2011 A1
20110039407 Nishizuka Feb 2011 A1
20110043228 Makhratchev et al. Feb 2011 A1
20110045676 Park Feb 2011 A1
20110048325 Choi et al. Mar 2011 A1
20110053380 Sapre et al. Mar 2011 A1
20110058303 Migita Mar 2011 A1
20110061810 Ganguly et al. Mar 2011 A1
20110061812 Ganguly et al. Mar 2011 A1
20110065276 Ganguly et al. Mar 2011 A1
20110076401 Chao et al. Mar 2011 A1
20110081782 Liang et al. Apr 2011 A1
20110088847 Law et al. Apr 2011 A1
20110100489 Orito May 2011 A1
20110101335 Yamazaki et al. May 2011 A1
20110104393 Hilkene et al. May 2011 A1
20110111596 Kanakasabapathy May 2011 A1
20110114601 Lubomirsky et al. May 2011 A1
20110115378 Lubomirsky et al. May 2011 A1
20110124144 Schlemm et al. May 2011 A1
20110127156 Foad et al. Jun 2011 A1
20110133650 Kim Jun 2011 A1
20110139748 Donnelly et al. Jun 2011 A1
20110140229 Rachmady et al. Jun 2011 A1
20110143542 Feurprier et al. Jun 2011 A1
20110146909 Shih et al. Jun 2011 A1
20110147363 Yap et al. Jun 2011 A1
20110151674 Tang et al. Jun 2011 A1
20110151677 Wang et al. Jun 2011 A1
20110151678 Ashtiani et al. Jun 2011 A1
20110155181 Inatomi Jun 2011 A1
20110159690 Chandrashekar et al. Jun 2011 A1
20110165057 Honda et al. Jul 2011 A1
20110165347 Miller et al. Jul 2011 A1
20110165771 Ring et al. Jul 2011 A1
20110174778 Sawada et al. Jul 2011 A1
20110180847 Ikeda et al. Jul 2011 A1
20110195575 Wang Aug 2011 A1
20110198034 Sun et al. Aug 2011 A1
20110204025 Tahara Aug 2011 A1
20110207332 Liu et al. Aug 2011 A1
20110217851 Liang et al. Sep 2011 A1
20110223334 Yudovsky et al. Sep 2011 A1
20110226734 Sumiya et al. Sep 2011 A1
20110227028 Sekar et al. Sep 2011 A1
20110230008 Lakshmanan et al. Sep 2011 A1
20110230052 Tang et al. Sep 2011 A1
20110232737 Ruletzki et al. Sep 2011 A1
20110232845 Riker et al. Sep 2011 A1
20110244686 Aso et al. Oct 2011 A1
20110244693 Tamura et al. Oct 2011 A1
20110256421 Bose et al. Oct 2011 A1
20110265884 Xu et al. Nov 2011 A1
20110265887 Lee et al. Nov 2011 A1
20110265951 Xu Nov 2011 A1
20110266252 Thadani et al. Nov 2011 A1
20110266256 Cruse et al. Nov 2011 A1
20110266682 Edelstein et al. Nov 2011 A1
20110278260 Lai et al. Nov 2011 A1
20110287633 Lee et al. Nov 2011 A1
20110294300 Zhang et al. Dec 2011 A1
20110298061 Siddiqui et al. Dec 2011 A1
20110303146 Nishijima Dec 2011 A1
20110304078 Lee et al. Dec 2011 A1
20110308453 Su et al. Dec 2011 A1
20120003782 Byun et al. Jan 2012 A1
20120009796 Cui et al. Jan 2012 A1
20120025289 Liang et al. Feb 2012 A1
20120031559 Dhindsa et al. Feb 2012 A1
20120034786 Dhindsa et al. Feb 2012 A1
20120035766 Shajii et al. Feb 2012 A1
20120037596 Eto et al. Feb 2012 A1
20120040492 Ovshinsky et al. Feb 2012 A1
20120052683 Kim et al. Mar 2012 A1
20120055402 Moriya et al. Mar 2012 A1
20120068242 Shin et al. Mar 2012 A1
20120070982 Yu et al. Mar 2012 A1
20120070996 Hao et al. Mar 2012 A1
20120073501 Lubomirsky et al. Mar 2012 A1
20120091108 Lin Xing et al. Apr 2012 A1
20120097330 Iyengar et al. Apr 2012 A1
20120100720 Winniczek et al. Apr 2012 A1
20120103518 Kakimoto May 2012 A1
20120104564 Won et al. May 2012 A1
20120119225 Shiomi et al. May 2012 A1
20120122302 Weidman et al. May 2012 A1
20120122319 Shimizu May 2012 A1
20120129354 Luong May 2012 A1
20120135576 Lee et al. May 2012 A1
20120148369 Michalski et al. Jun 2012 A1
20120149200 Culp et al. Jun 2012 A1
20120161405 Mohn et al. Jun 2012 A1
20120164839 Nishimura Jun 2012 A1
20120171852 Yuan et al. Jul 2012 A1
20120180954 Yang et al. Jul 2012 A1
20120181599 Lung Jul 2012 A1
20120182808 Lue et al. Jul 2012 A1
20120187844 Hoffman et al. Jul 2012 A1
20120196447 Yang et al. Aug 2012 A1
20120196451 Mallick Aug 2012 A1
20120202408 Shajii et al. Aug 2012 A1
20120208361 Ha Aug 2012 A1
20120211462 Zhang et al. Aug 2012 A1
20120211722 Kellam et al. Aug 2012 A1
20120222616 Han et al. Sep 2012 A1
20120222815 Sabri et al. Sep 2012 A1
20120223048 Paranjpe et al. Sep 2012 A1
20120223418 Stowers et al. Sep 2012 A1
20120225557 Serry et al. Sep 2012 A1
20120228642 Aube et al. Sep 2012 A1
20120234945 Olgado Sep 2012 A1
20120238102 Zhang et al. Sep 2012 A1
20120238103 Zhang et al. Sep 2012 A1
20120238108 Chen et al. Sep 2012 A1
20120241411 Darling et al. Sep 2012 A1
20120247390 Sawada et al. Oct 2012 A1
20120247670 Dobashi et al. Oct 2012 A1
20120247671 Sugawara Oct 2012 A1
20120247677 Himori et al. Oct 2012 A1
20120255491 Hahidi Oct 2012 A1
20120258600 Godet et al. Oct 2012 A1
20120258607 Holland et al. Oct 2012 A1
20120267346 Kao et al. Oct 2012 A1
20120269968 Rayner Oct 2012 A1
20120282779 Arnold et al. Nov 2012 A1
20120285619 Matyushkin et al. Nov 2012 A1
20120285621 Tan Nov 2012 A1
20120291696 Clarke Nov 2012 A1
20120292664 Kanike Nov 2012 A1
20120304933 Mai et al. Dec 2012 A1
20120309204 Kang et al. Dec 2012 A1
20120309205 Wang et al. Dec 2012 A1
20120322015 Kim Dec 2012 A1
20130001899 Hwang et al. Jan 2013 A1
20130005103 Liu et al. Jan 2013 A1
20130005140 Jeng et al. Jan 2013 A1
20130012030 Lakshmanan et al. Jan 2013 A1
20130012032 Liu et al. Jan 2013 A1
20130023062 Masuda et al. Jan 2013 A1
20130023094 Yeh et al. Jan 2013 A1
20130023124 Nemani et al. Jan 2013 A1
20130023125 Singh Jan 2013 A1
20130026135 Kim Jan 2013 A1
20130032574 Liu et al. Feb 2013 A1
20130034666 Liang et al. Feb 2013 A1
20130034968 Zhang et al. Feb 2013 A1
20130037919 Sapra et al. Feb 2013 A1
20130045605 Wang et al. Feb 2013 A1
20130049592 Yeom et al. Feb 2013 A1
20130052804 Song Feb 2013 A1
20130052827 Wang et al. Feb 2013 A1
20130052833 Ranjan et al. Feb 2013 A1
20130059440 Wang et al. Mar 2013 A1
20130059448 Marakhtanov et al. Mar 2013 A1
20130062675 Thomas Mar 2013 A1
20130065398 Ohsawa et al. Mar 2013 A1
20130082197 Yang et al. Apr 2013 A1
20130084654 Gaylord et al. Apr 2013 A1
20130087309 Volfovski Apr 2013 A1
20130089988 Wang et al. Apr 2013 A1
20130095646 Alsmeier et al. Apr 2013 A1
20130098868 Nishimura et al. Apr 2013 A1
20130105303 Lubomirsky et al. May 2013 A1
20130105948 Kewley May 2013 A1
20130107415 Banna et al. May 2013 A1
20130112383 Hanamachi May 2013 A1
20130115372 Pavol et al. May 2013 A1
20130118686 Carducci et al. May 2013 A1
20130119016 Kagoshima May 2013 A1
20130119457 Lue et al. May 2013 A1
20130119483 Alptekin et al. May 2013 A1
20130130507 Wang et al. May 2013 A1
20130133578 Hwang May 2013 A1
20130149866 Shriner Jun 2013 A1
20130150303 Kungl et al. Jun 2013 A1
20130152859 Collins et al. Jun 2013 A1
20130155568 Todorow et al. Jun 2013 A1
20130161726 Kim et al. Jun 2013 A1
20130171810 Sun et al. Jul 2013 A1
20130171827 Cho et al. Jul 2013 A1
20130175654 Muckenhirn et al. Jul 2013 A1
20130187220 Surthi Jul 2013 A1
20130193108 Zheng Aug 2013 A1
20130213935 Liao et al. Aug 2013 A1
20130217243 Underwood et al. Aug 2013 A1
20130224953 Salinas et al. Aug 2013 A1
20130224960 Payyapilly et al. Aug 2013 A1
20130260533 Sapre et al. Oct 2013 A1
20130260564 Sapre et al. Oct 2013 A1
20130276983 Park et al. Oct 2013 A1
20130279066 Lubomirsky et al. Oct 2013 A1
20130284369 Kobayashi et al. Oct 2013 A1
20130284370 Kobayashi et al. Oct 2013 A1
20130284373 Sun et al. Oct 2013 A1
20130284374 Lubomirsky et al. Oct 2013 A1
20130284700 Nangoy et al. Oct 2013 A1
20130286530 Lin et al. Oct 2013 A1
20130295297 Chou et al. Nov 2013 A1
20130298942 Ren et al. Nov 2013 A1
20130302980 Chandrashekar et al. Nov 2013 A1
20130320550 Kim Dec 2013 A1
20130337655 Lee et al. Dec 2013 A1
20130343829 Benedetti et al. Dec 2013 A1
20140004707 Thedjoisworo et al. Jan 2014 A1
20140004708 Thedjoisworo Jan 2014 A1
20140008880 Miura et al. Jan 2014 A1
20140020708 Kim et al. Jan 2014 A1
20140021673 Chen et al. Jan 2014 A1
20140026813 Wang et al. Jan 2014 A1
20140053866 Baluja et al. Feb 2014 A1
20140054269 Hudson et al. Feb 2014 A1
20140057447 Yang et al. Feb 2014 A1
20140062285 Chen Mar 2014 A1
20140065827 Kang et al. Mar 2014 A1
20140065842 Anthis et al. Mar 2014 A1
20140076234 Kao et al. Mar 2014 A1
20140080308 Chen et al. Mar 2014 A1
20140080309 Park Mar 2014 A1
20140080310 Chen et al. Mar 2014 A1
20140083362 Lubomirsky et al. Mar 2014 A1
20140087488 Nam et al. Mar 2014 A1
20140097270 Liang et al. Apr 2014 A1
20140099794 Ingle et al. Apr 2014 A1
20140102367 Ishibashi Apr 2014 A1
20140110061 Okunishi Apr 2014 A1
20140124364 Yoo et al. May 2014 A1
20140134842 Zhange et al. May 2014 A1
20140134847 Seya May 2014 A1
20140141621 Ren et al. May 2014 A1
20140147126 Yamashita et al. May 2014 A1
20140152312 Snow et al. Jun 2014 A1
20140154668 Chou et al. Jun 2014 A1
20140154889 Wang et al. Jun 2014 A1
20140165912 Kao et al. Jun 2014 A1
20140166617 Chen et al. Jun 2014 A1
20140166618 Tadigadapa et al. Jun 2014 A1
20140175530 Chien et al. Jun 2014 A1
20140175534 Kofuji et al. Jun 2014 A1
20140186772 Pohlers et al. Jul 2014 A1
20140190410 Kim Jul 2014 A1
20140190632 Kumar et al. Jul 2014 A1
20140191388 Chen Jul 2014 A1
20140199850 Kim et al. Jul 2014 A1
20140199851 Nemani et al. Jul 2014 A1
20140209245 Yamamoto et al. Jul 2014 A1
20140216337 Swaminathan et al. Aug 2014 A1
20140225504 Kaneko et al. Aug 2014 A1
20140227881 Lubomirsky et al. Aug 2014 A1
20140234466 Gao et al. Aug 2014 A1
20140248773 Tsai et al. Sep 2014 A1
20140248780 Ingle et al. Sep 2014 A1
20140251956 Jeon et al. Sep 2014 A1
20140253900 Cornelissen et al. Sep 2014 A1
20140256131 Wang et al. Sep 2014 A1
20140256145 Abdallah et al. Sep 2014 A1
20140262031 Belostotskiy et al. Sep 2014 A1
20140262038 Wang et al. Sep 2014 A1
20140263172 Xie et al. Sep 2014 A1
20140263272 Duan et al. Sep 2014 A1
20140264507 Lee et al. Sep 2014 A1
20140264533 Simsek-Ege Sep 2014 A1
20140271097 Wang et al. Sep 2014 A1
20140273373 Makala et al. Sep 2014 A1
20140273406 Wang et al. Sep 2014 A1
20140273451 Wang et al. Sep 2014 A1
20140273462 Simsek-Ege et al. Sep 2014 A1
20140273487 Deshmukh et al. Sep 2014 A1
20140273489 Wang et al. Sep 2014 A1
20140273491 Zhang et al. Sep 2014 A1
20140273492 Anthis et al. Sep 2014 A1
20140273496 Kao Sep 2014 A1
20140288528 Py et al. Sep 2014 A1
20140302678 Paterson et al. Oct 2014 A1
20140302680 Singh Oct 2014 A1
20140308758 Nemani et al. Oct 2014 A1
20140308816 Wang et al. Oct 2014 A1
20140311581 Belostotskiy et al. Oct 2014 A1
20140342532 Zhu Nov 2014 A1
20140342569 Zhu et al. Nov 2014 A1
20140349477 Chandrashekar et al. Nov 2014 A1
20140357083 Ling et al. Dec 2014 A1
20140361684 Ikeda et al. Dec 2014 A1
20140363977 Morimoto et al. Dec 2014 A1
20140363979 Or et al. Dec 2014 A1
20140373782 Park et al. Dec 2014 A1
20150007770 Chandrasekharan et al. Jan 2015 A1
20150011096 Chandrasekharan et al. Jan 2015 A1
20150014152 Hoinkis et al. Jan 2015 A1
20150031211 Sapre et al. Jan 2015 A1
20150037980 Rha Feb 2015 A1
20150041430 Yoshino et al. Feb 2015 A1
20150050812 Smith Feb 2015 A1
20150056814 Ling et al. Feb 2015 A1
20150060265 Cho et al. Mar 2015 A1
20150064918 Ranjan et al. Mar 2015 A1
20150072508 Or et al. Mar 2015 A1
20150076110 Wu et al. Mar 2015 A1
20150076586 Rabkin et al. Mar 2015 A1
20150079797 Chen et al. Mar 2015 A1
20150093891 Zope Apr 2015 A1
20150118822 Zhang et al. Apr 2015 A1
20150118858 Takaba Apr 2015 A1
20150123541 Baek et al. May 2015 A1
20150126035 Diao et al. May 2015 A1
20150126039 Korolik et al. May 2015 A1
20150126040 Korolik et al. May 2015 A1
20150129541 Wang et al. May 2015 A1
20150129545 Ingle et al. May 2015 A1
20150129546 Ingle et al. May 2015 A1
20150132953 Nowling May 2015 A1
20150132968 Ren et al. May 2015 A1
20150140827 Kao et al. May 2015 A1
20150152072 Cantat et al. Jun 2015 A1
20150155177 Zhang et al. Jun 2015 A1
20150167705 Lee et al. Jun 2015 A1
20150170811 Tanigawa et al. Jun 2015 A1
20150170879 Nguyen et al. Jun 2015 A1
20150170920 Purayath et al. Jun 2015 A1
20150170924 Nguyen et al. Jun 2015 A1
20150170926 Michalak Jun 2015 A1
20150170935 Wang et al. Jun 2015 A1
20150170943 Nguyen et al. Jun 2015 A1
20150171008 Luo Jun 2015 A1
20150179464 Wang et al. Jun 2015 A1
20150187625 Busche et al. Jul 2015 A1
20150191823 Banna et al. Jul 2015 A1
20150194435 Lee Jul 2015 A1
20150200042 Ling et al. Jul 2015 A1
20150206764 Wang et al. Jul 2015 A1
20150214066 Luere et al. Jul 2015 A1
20150214067 Zhang et al. Jul 2015 A1
20150214092 Purayath et al. Jul 2015 A1
20150214101 Ren et al. Jul 2015 A1
20150214337 Ko et al. Jul 2015 A1
20150221479 Chen et al. Aug 2015 A1
20150221541 Nemani et al. Aug 2015 A1
20150228456 Ye et al. Aug 2015 A1
20150235809 Ito et al. Aug 2015 A1
20150235860 Tomura et al. Aug 2015 A1
20150235863 Chen Aug 2015 A1
20150235865 Wang et al. Aug 2015 A1
20150235867 Nishizuka Aug 2015 A1
20150240359 Jdira et al. Aug 2015 A1
20150247231 Nguyen et al. Sep 2015 A1
20150249018 Park et al. Sep 2015 A1
20150255481 Baenninger et al. Sep 2015 A1
20150270105 Kobayashi et al. Sep 2015 A1
20150270140 Gupta et al. Sep 2015 A1
20150275361 Lubomirsky et al. Oct 2015 A1
20150275375 Kim et al. Oct 2015 A1
20150279687 Xue et al. Oct 2015 A1
20150294980 Lee et al. Oct 2015 A1
20150303031 Choi Oct 2015 A1
20150332930 Wang et al. Nov 2015 A1
20150332953 Futase et al. Nov 2015 A1
20150340225 Kim et al. Nov 2015 A1
20150340371 Lue Nov 2015 A1
20150345029 Wang et al. Dec 2015 A1
20150357201 Chen et al. Dec 2015 A1
20150357205 Wang et al. Dec 2015 A1
20150371861 Li et al. Dec 2015 A1
20150371864 Hsu et al. Dec 2015 A1
20150371865 Chen et al. Dec 2015 A1
20150371866 Chen et al. Dec 2015 A1
20150371877 Lin et al. Dec 2015 A1
20150376782 Griffin et al. Dec 2015 A1
20150380419 Gunji-Yoneoka et al. Dec 2015 A1
20150380431 Kanamori et al. Dec 2015 A1
20160005572 Liang et al. Jan 2016 A1
20160005833 Collins et al. Jan 2016 A1
20160020071 Khaja et al. Jan 2016 A1
20160027654 Kim et al. Jan 2016 A1
20160027673 Wang et al. Jan 2016 A1
20160035586 Purayath et al. Feb 2016 A1
20160035614 Purayath et al. Feb 2016 A1
20160042920 Cho et al. Feb 2016 A1
20160042968 Purayath et al. Feb 2016 A1
20160043099 Purayath et al. Feb 2016 A1
20160056167 Wang et al. Feb 2016 A1
20160056235 Lee et al. Feb 2016 A1
20160064212 Thedjoisworo et al. Mar 2016 A1
20160064233 Wang et al. Mar 2016 A1
20160079062 Zheng et al. Mar 2016 A1
20160079072 Wang et al. Mar 2016 A1
20160083844 Nishitani et al. Mar 2016 A1
20160086772 Khaja Mar 2016 A1
20160086807 Park et al. Mar 2016 A1
20160086808 Zhang et al. Mar 2016 A1
20160086815 Pandit et al. Mar 2016 A1
20160086816 Wang et al. Mar 2016 A1
20160093505 Chen et al. Mar 2016 A1
20160093506 Chen et al. Mar 2016 A1
20160093737 Li et al. Mar 2016 A1
20160099173 Agarwal et al. Apr 2016 A1
20160104606 Park et al. Apr 2016 A1
20160104648 Park et al. Apr 2016 A1
20160109863 Valcore et al. Apr 2016 A1
20160117425 Povolny et al. Apr 2016 A1
20160118227 Valcore et al. Apr 2016 A1
20160118268 Ingle et al. Apr 2016 A1
20160118396 Rabkin et al. Apr 2016 A1
20160126118 Chen et al. May 2016 A1
20160133480 Ko et al. May 2016 A1
20160136660 Song May 2016 A1
20160141419 Baenninger et al. May 2016 A1
20160148805 Jongbloed et al. May 2016 A1
20160148821 Singh et al. May 2016 A1
20160163512 Lubomirsky Jun 2016 A1
20160163513 Lubomirsky Jun 2016 A1
20160172216 Marakhtanov et al. Jun 2016 A1
20160181112 Xue et al. Jun 2016 A1
20160181116 Berry et al. Jun 2016 A1
20160189933 Kobayashi et al. Jun 2016 A1
20160190147 Kato et al. Jun 2016 A1
20160196969 Berry et al. Jul 2016 A1
20160196984 Lill et al. Jul 2016 A1
20160196985 Tan et al. Jul 2016 A1
20160203958 Arase et al. Jul 2016 A1
20160204009 Nguyen et al. Jul 2016 A1
20160208395 Ooshima Jul 2016 A1
20160218018 Lieu et al. Jul 2016 A1
20160222522 Wang et al. Aug 2016 A1
20160225651 Tran et al. Aug 2016 A1
20160225652 Tran et al. Aug 2016 A1
20160237570 Tan et al. Aug 2016 A1
20160240353 Nagami Aug 2016 A1
20160240389 Zhang et al. Aug 2016 A1
20160240402 Park et al. Aug 2016 A1
20160260588 Park et al. Sep 2016 A1
20160260616 Li et al. Sep 2016 A1
20160260619 Zhang et al. Sep 2016 A1
20160284556 Ingle et al. Sep 2016 A1
20160293398 Danek et al. Oct 2016 A1
20160293438 Zhou et al. Oct 2016 A1
20160300694 Yang et al. Oct 2016 A1
20160307772 Choi et al. Oct 2016 A1
20160307773 Lee et al. Oct 2016 A1
20160314961 Liu et al. Oct 2016 A1
20160314985 Yang et al. Oct 2016 A1
20160319452 Eidschun et al. Nov 2016 A1
20160340781 Thomas et al. Nov 2016 A1
20160343548 Howald et al. Nov 2016 A1
20160358793 Okumara et al. Dec 2016 A1
20170011922 Tanimura et al. Jan 2017 A1
20170040175 Xu et al. Feb 2017 A1
20170040180 Xu et al. Feb 2017 A1
20170040190 Benjaminson et al. Feb 2017 A1
20170040191 Benjaminson et al. Feb 2017 A1
20170040207 Purayath Feb 2017 A1
20170040214 Lai et al. Feb 2017 A1
20170053808 Kamp et al. Feb 2017 A1
20170062184 Tran et al. Mar 2017 A1
20170110290 Kobayashi et al. Apr 2017 A1
20170110335 Yang et al. Apr 2017 A1
20170110475 Liu et al. Apr 2017 A1
20170121818 Dunn et al. May 2017 A1
20170133202 Berry May 2017 A1
20170169995 Kim et al. Jun 2017 A1
20170178894 Stone et al. Jun 2017 A1
20170178899 Kabansky et al. Jun 2017 A1
20170178924 Chen et al. Jun 2017 A1
20170194128 Lai et al. Jul 2017 A1
20170207088 Kwon et al. Jul 2017 A1
20170226637 Lubomirsky et al. Aug 2017 A1
20170229287 Xu et al. Aug 2017 A1
20170229289 Lubomirsky et al. Aug 2017 A1
20170229291 Singh et al. Aug 2017 A1
20170229293 Park et al. Aug 2017 A1
20170229326 Tran et al. Aug 2017 A1
20170229328 Benjaminson et al. Aug 2017 A1
20170229329 Benjaminson et al. Aug 2017 A1
20170236691 Liang et al. Aug 2017 A1
20170236694 Eason et al. Aug 2017 A1
20170250193 Huo Aug 2017 A1
20170294445 Son et al. Oct 2017 A1
20170306494 Lin et al. Oct 2017 A1
20170309509 Tran et al. Oct 2017 A1
20170316935 Tan et al. Nov 2017 A1
20170338133 Tan et al. Nov 2017 A1
20170338134 Tan et al. Nov 2017 A1
20170350011 Marquardt Dec 2017 A1
20170373082 Sekine et al. Dec 2017 A1
20180005850 Citla et al. Jan 2018 A1
20180006050 Watanabe et al. Jan 2018 A1
20180025900 Park et al. Jan 2018 A1
20180069000 Bergendahl et al. Mar 2018 A1
20180076031 Yan et al. Mar 2018 A1
20180076044 Choi et al. Mar 2018 A1
20180076083 Ko et al. Mar 2018 A1
20180080124 Bajaj et al. Mar 2018 A1
20180082861 Citla et al. Mar 2018 A1
20180096818 Lubomirsky Apr 2018 A1
20180096819 Lubomirsky et al. Apr 2018 A1
20180096821 Lubomirsky et al. Apr 2018 A1
20180096865 Lubomirsky et al. Apr 2018 A1
20180102255 Chen et al. Apr 2018 A1
20180102256 Chen et al. Apr 2018 A1
20180102259 Wang et al. Apr 2018 A1
20180130818 Kim et al. May 2018 A1
20180138049 Ko et al. May 2018 A1
20180138055 Xu et al. May 2018 A1
20180138075 Kang et al. May 2018 A1
20180138085 Wang et al. May 2018 A1
20180175051 Lue et al. Jun 2018 A1
20180182633 Pandit et al. Jun 2018 A1
20180182777 Cui et al. Jun 2018 A1
20180223437 George et al. Aug 2018 A1
20180226223 Lubomirsky Aug 2018 A1
20180226230 Kobayashi et al. Aug 2018 A1
20180226259 Choi et al. Aug 2018 A1
20180226278 Arnepalli et al. Aug 2018 A1
20180226425 Purayath Aug 2018 A1
20180226426 Purayath Aug 2018 A1
20180240654 Park et al. Aug 2018 A1
20180261516 Lin et al. Sep 2018 A1
20180261686 Lin et al. Sep 2018 A1
20180366351 Lubomirsky Dec 2018 A1
Foreign Referenced Citations (99)
Number Date Country
1124364 Jun 1996 CN
1847450 Oct 2006 CN
101236893 Aug 2008 CN
101378850 Mar 2009 CN
102893705 Jan 2013 CN
1675160 Jun 2006 EP
S59-126778 Jul 1984 JP
S62-45119 Feb 1987 JP
63301051 Dec 1988 JP
H01-200627 Aug 1989 JP
H02-114525 Apr 1990 JP
H07-153739 Jun 1995 JP
H8-31755 Feb 1996 JP
H08-107101 Apr 1996 JP
H08-264510 Oct 1996 JP
H09-260356 Oct 1997 JP
2001-313282 Nov 2001 JP
2001-332608 Nov 2001 JP
2002-075972 Mar 2002 JP
2002-083869 Mar 2002 JP
2003-174020 Jun 2003 JP
2003-282591 Oct 2003 JP
2004-508709 Mar 2004 JP
2004-296467 Oct 2004 JP
2005-050908 Feb 2005 JP
2006-041039 Feb 2006 JP
2006-066408 Mar 2006 JP
2008-288560 Nov 2008 JP
4191137 Dec 2008 JP
2009-141343 Jun 2009 JP
2009-530871 Aug 2009 JP
2009-239056 Oct 2009 JP
2010-180458 Aug 2010 JP
2011-508436 Mar 2011 JP
2011-518408 Jun 2011 JP
4763293 Aug 2011 JP
2011-171378 Sep 2011 JP
2012-19164 Jan 2012 JP
2012-019194 Jan 2012 JP
2012-512531 May 2012 JP
2013-243418 Dec 2013 JP
5802323 Oct 2015 JP
2016-111177 Jun 2016 JP
10-2000-008278 Feb 2000 KR
10-2000-0064946 Nov 2000 KR
10-2001-0056735 Jul 2001 KR
2003-0023964 Mar 2003 KR
10-2003-0054726 Jul 2003 KR
10-2003-0083663 Oct 2003 KR
100441297 Jul 2004 KR
10-2005-0007143 Jan 2005 KR
10-2005-0042701 May 2005 KR
2005-0049903 May 2005 KR
10-2006-0080509 Jul 2006 KR
1006-41762 Nov 2006 KR
10-2006-0127173 Dec 2006 KR
100663668 Jan 2007 KR
100678696 Jan 2007 KR
100712727 Apr 2007 KR
2007-0079870 Aug 2007 KR
10-2008-0063988 Jul 2008 KR
10-0843236 Jul 2008 KR
10-2009-0040869 Apr 2009 KR
10-2009-0128913 Dec 2009 KR
10-2010-0013980 Feb 2010 KR
10-2010-0093358 Aug 2010 KR
10-2011-0086540 Jul 2011 KR
10-2011-0114538 Oct 2011 KR
10-2011-0126675 Nov 2011 KR
10-2012-0022251 Mar 2012 KR
10-2012-0082640 Jul 2012 KR
10-2016-0002543 Jan 2016 KR
565903 Dec 2003 TW
2006-12480 Apr 2006 TW
M299917 Oct 2006 TW
200709256 Mar 2007 TW
2007-35196 Sep 2007 TW
2011-27983 Aug 2011 TW
2012-07919 Feb 2012 TW
2012-13594 Apr 2012 TW
2012-33842 Aug 2012 TW
2016-08935 Mar 2016 TW
I609442 Dec 2017 TW
2018-14787 Apr 2018 TW
2008-112673 Sep 2008 WO
2009-009611 Jan 2009 WO
2009-084194 Jul 2009 WO
2010-010706 Jan 2010 WO
2010-113946 Oct 2010 WO
2011-027515 Mar 2011 WO
2011-031556 Mar 2011 WO
2011070945 Jun 2011 WO
2011-095846 Aug 2011 WO
2011-149638 Dec 2011 WO
2012-050321 Jul 2012 WO
2012-118987 Sep 2012 WO
2012-125656 Sep 2012 WO
2012-148568 Nov 2012 WO
2013-118260 Aug 2013 WO
Non-Patent Literature Citations (14)
Entry
Won et al. Derwent 2006-065772; Sep. 7, 2014, 10 pages.
H. Xiao, Introduction to Semiconductor Manufacturing Technology, published by Prentice Hall, 2001, ISBN 0-13-022404-9, pp. 354-356.
Manual No. TQMA72E1. “Bayard-Alpert Pirani Gauge FRG-730: Short Operating Instructions” Mar. 2012. Agilent Technologies, Lexington, MA 02421, USA. pp. 1-45.
International Search Report and Written Opinion of PCT/US2016/045551 dated Nov. 17, 2016, all pages.
International Search Report and Written Opinion of PCT/US2016/045543 dated Nov. 17, 2016, all pages.
“Liang et al. Industrial Application of Plasma Process vol. 3, pp. 61-74, 2010”.
Instrument Manual: Vacuum Gauge Model MM200, Rev D. TELEVAC (website: www.televac.com), A Division of the Fredericks Company, Huntingdon Valley, PA, US. 2008. pp. 162.
J.J. Wang and et al., “Inductively coupled plasma etching of bulk 1-20 6H-SiC and thin-film SiCN in NF3 chemistries,” Journal of Vacuum Science & Technology A: Vacuum, Surfaces, and Films 16, 2204 (1998).
International Search Report and Written Opinion of PCT/US2017/047209 dated Nov. 24, 2017, all pages.
International Search Report and Written Opinion of PCT/US2017/033362 dated Aug. 24, 2017, all pages.
International Search Report and Written Opinion of PCT/US2017/060696 dated Jan. 25, 2018, all pages.
International Search Report and Written Opinion of PCT/US2017/055431 dated Jan. 19, 2018, all pages.
International Search Report and Written Opinion of PCT/US2018/016261 dated May 21, 2018, all pages.
International Search Report and Written Opinion of PCT/US2018/016648 dated May 18, 2018, all pages.
Related Publications (1)
Number Date Country
20190318911 A1 Oct 2019 US